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Campylobacter jejuni/coli have been known to be major bacterial causes of human 
gastroenteritis worldwide for decades.  Regarding its pathogenicity, little is known yet.  A 
better understanding of the pathogenic mechanisms will provide important information, 
not only for generating molecular markers to differentiate pathogenic strains versus non-
pathogenic ones; but also for developing rational strategies to prevent and control 
Campylobacter-caused disease.  The objectives of this study were to characterize the 
pathogenic abilities of various C. jejuni/coli retail meat isolates, including their abilities 
to adhere to, invade into and transmigrate across human epithelial cells, to examine the 
role of NF-κB pathway in IL-8 secretion induced by Campylobacter, and to identify C. 
jejuni-specific adherence/invasion genes during host pathogen interaction.  It was found 
that the adherence and invasiveness of total 43 Campylobacter retail meat isolates in 
human intestinal epithelial T84 cell model indicated that C. jejuni/coli present in retail 
meat were considerably diverse in their ability to adhere to and invade human epithelial 
cells.  Meanwhile, eight putative virulence genes, determined by PCR, were shown to be 
widespread among the Campylobacter isolates. C. jejuni /coli–induced proinflammatory 
 
cytokine Interleukin (IL)-8 secretion in polarized human colonic epithelial cells T84 was 
examined, and the role of NF-κB pathway in Campylobacter-induced IL-8 secretion was 
determined.  Data suggested that C. jejuni/coli induce basolateral-polarized secretion of 
IL-8 in human intestinal epithelial cells, and C. jejuni-induced IL-8 secretion is NF-κB-
dependent.  The effort to identify C. jejuni-specific adherence/invasion genes during host 
pathogen interaction by using restriction fragment differential display PCR (RFDD-PCR) 
has been made.  As a result, it was not successful. However this study still provides 
useful information and experience on the application of this technique for prokaryotic 
gene expression analysis during host pathogen interaction, which remains an unexplored 
area.  In summary, Campylobacter retail meat isolates exhibited wide diversity in cell 
culture model in the ability of adherence, invasion and transmigration.  As the first line 
defense, intestinal epithelium activates NF-κB and secretes proinflammatory cytokine IL-
8 in response to Campylobacter infection.  Multiple virulence factors have roles in 
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CHAPTER I.  LITERATURE REVIEW 
 
Overview 
Foodborne disease is caused by consumption of contaminated foods or beverages.  
More than 250 foodborne diseases have been described, in which most of them are 
infectious.  An estimated approximately 76 million illnesses, 325,000 hospitalizations, 
and 5,000 deaths related to foodborne diseases occur each year in the United States (150).  
Known pathogens account for an estimated 14 million cases, 60,000 hospitalizations, and 
1,800 deaths annually (150).  Campylobacter is one of the most common bacterial causes 
of foodborne gastroenteritis in the United States, although the incidence of Campylobacter 
infection decreased by 28% from 1996 through 2003 (2).  Currently, the Center for 
Disease Control and Prevention (CDC) estimates that about 2.4 million cases of 
Campylobacter infection, involving almost 1% of the entire population, and 124 fatal 
cases occur in the United States each year (74).  A detailed study of 53 routinely 
diagnosed sporadic cases in the United Kingdom gave a figure of $480 per case for health 
care and lost productivity and more than twice this sum if allowance was made for “pain 
and suffering” (207).  Costs in United States are likely to be at least as high. Therefore, 
Campylobacter infection is consequently responsible for a major public health and 
economic burden (214).  
Campylobacter jejuni was first isolated as Vibrio fetus in 1909 from spontaneous 
abortions in livestock (118).  Campylobacter infections were not recognized until the 
development and increasingly widespread use of selective media for isolation of 
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Campylobacter from stool sample in the 1970s.  By the 1980s, it had been determined 
that Campylobacter species are one of the most common bacterial causes of 
gastroenteritis worldwide.  In the following decade substantial advances have been made 
in the classification, identification, epidemiology, diagnosis, and isolation technology, 
and the pathogenesis and molecular biology of Campylobacter species. 
 
General characteristics of Campylobacter 
Campylobacter species are Gram-negative slender rods with pleomorphic helical 
shape.  The organisms are motile by means of unipolar or bipolar flagella.  Most species 
grow best at 42ºC and need microaerophilic (5% O2, 10% CO2, 85% N2) condition.  
Biochemical reactions by which Campylobacter species may be differentiated are 
relatively few due to the inability to ferment or oxidize the usual carbohydrate substances 
available in the diagnostic laboratory (61, 162, 216).  
The genus Campylobacter currently includes 15 species and 6 subspecies by 
rRNA sequencing (Table I-1) (184).  Among 15 species, 12 species are associated with 
human diseases. Remarkably, 99% of reported Campylobacter enteritis are caused by 
Campylobacter jejuni (C. jejuni) followed by Campylobacter coli (C. coli) in the United 
States (74).  C. jejuni is a simply referral of C. jejuni subsp. jejuni. C. jejuni usually 
carries as a commensal by a wide range of animal hosts, including chickens, cattle, pigs, 
sheep, dogs, and ostriches (206).  C. coli was first isolated from pigs afflicted with 
infectious dysentery (57).  It remains a frequently encountered species in pigs.
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Table I-1. Differential reactions and characteristics for species of the genus Campylobactera
Reactions and charactericsb
Growth 
Species Catalase  Nitrate H2S (TSI) Hippurate
Indoxyl







C. fetus subsp. fetus           + + - - - + + (-) + - 33-34
C. fetus subsp. 
venerealis 
+          
          
           
           
           
           
           
           
           
           
          
           
           
           
           
           
+ - - - + + - - - 33-34
C. Hyointestinalis + + + - - (+) + + + + 35-36
C. jejuni + + - + + - + + + - 30-32
C. coli + + - - + - + + + - 31-33
C. laridis + + - - - - + + + + 31-33
C. upsaliensis + + - - ND - + + - - 35-36
C. cinaedi (-) + - - (-) - + - + - 37-38
C. fennelliae + + - - + - + - + - 37-38
C. cryaerophila + - - - + + + - - ND 29-30
C. nitrofigilis + + - - - + + - - ND 28-29
 C. sputorum 
      Biovar sputorum - + (+) - - - + + + d 31-32 
      Biovar bubulus - + + - - - + + + + 31-32 
      Biovar faecalis + + + - - - + + + + 32-33 
      Biovar 
paraureolyticus 
- + + - - - + + + + 31-32
C. mucosalis - + + - + + + + - 38-39
C. concisus - + + - ND - + + + - 38-39
C. pylori + d - - - - + + d ND 36-37
C. hyoilei + + + - ND - + + + ND 34-35
a Data were obtained from references (7, 28, 37, 75, 114, 147, 158, 169, 174, 184, 191, 192); b +, Positive reaction; -, negative reaction; ND, no test 
results found; (+), most strains positive but a low percentage negative; (-), most strains negative but some positive or weakly positive; d, different 
reactions.  
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Clinical characteristics of Campylobacter gastroenteritis 
The clinical manifestation of patients with C. jejuni infection differs between 
developing and industrialized countries.  In the industrialized world, most commonly, the 
usual manifestation of Campylobacter enteritis is a very unpleasant attack of acute 
diarrhea lasting about five days.  The characteristic pathology is an acute inflammatory 
enterocolitis; stool microscopy almost invariably shows the presence of cellular exudates, 
and frank blood is visible in the stools of about one-quarter of patients.  Fever, vomiting, 
and abdominal cramps are common in the early stages of the disease (175).  However, in 
the developing countries, infection could be asymptomatic or mild noninflammatory 
diarrhea, predominantly affecting young children (100).  But strains isolated from such 
children, who are symptomatic or not, produce acute inflammatory diseases in 
nonimmune visitors form developed countries.  The explanation for the different disease 
expression in developing countries and developed countries is the early acquisition of 
immunity by children exposed to hyperendemic infection.  Following gastroenteritis, late 
onset complications include pancreatitis, meningitis, endocarditis, septic arthritis, 
osteomyelitis, and neonatal sepsis.  Most recently, C. jejuni is also been shown to 
associated with immunoproliferative small intestinal disease (135).  Guilliain-Barré 
syndrome (GBS) is the most important postinfectious complication of C. jejuni.  GBS is 
an acute, immune system-mediated polyneuropathy, leading to ascending paralysis.  GBS 
affects 1-2 persons per 100,000-population in the United States each year.  The risk of 
developing GBS is increased after infection with certain Campylobacter serotypes in a 




Africa (8).  However, the severity of C. jejuni infection is not associated with an risk of 
GBS development (130).  Carbohydrate mimicry between human ganglioside GM1 and 
C. jejuni lipooligosaccharide appears to the key of GBS (233). 
 
Epidemiology of Campylobacter 
Campylobacter sporadic infections in humans far outnumber the cases linked to 
outbreaks (181).  The age and sex distributions of Campylobacter infections are 
distinctive from other bacterial enteric pathogens.  In the United States and industrialized 
countries, peak incidence occurs in children below one year of age and young adults, at 
15-44 years old and males take preponderance among infected persons (74).  The reasons 
for these distributions remain unknown. A distinct seasonality in Campylobacter 
transmission is present worldwide, with most showing a peak in spring (199).  The timing 
of infection peak is weakly associated with high temperatures three months previously 
(199). 
The most important source leading to Campylobacter infection in the United 
States and other industrialized nations remains the consumption and handling of chicken. 
Studies showed in many parts of the United States, Great Britain, 50%-70% of all 
Campylobacter infections have been attributed to consumption of chicken (3, 86).  It 
should not be surprising in light of the frequency with which poultry products are 
consumed and the high contamination of chicken carcasses with Campylobacter (70%-




Campylobacter contamination of fresh chicken carcasses in June (152) may contribute to 
the seasonality of human Campylobacter infection.  Unpasteurized milk and non-
chlorinated water are also the sources of Campylobacter infection (35, 74, 156).  
Transmission of Campylobacter to humans is mainly via direct contact with 
contaminated animals or carcasses, and ingestion of contaminated food and water due to 
the relatively low infectious dose (500 organisms) (1).  Campylobacter contamination of 
fresh produce also poses a risk to consumers (112).  
The epidemiology of Campylobacter infections in developing countries is 
hyperendemic in young children and asymptomatic carriage in adults, quite different 
from developed countries.  Nevertheless, Campylobacter remains one of the most 
common bacterial causes of diarrhea in both developed and developing countries. 
 
Treatment and antimicrobial resistance 
Campylobacter infections are generally self-limiting and do not require antibiotic 
treatment. Maintenance of hydration and electrolyte balance is the cornerstone of 
treatment for Campylobacter enteritis.  Early antibiotic treatment can reduce the fecal 
shedding period effectively, but has nothing to do with the duration or severity of 
diarrhea, abdominal pain, or other symptoms (226).  Erythromycin continues to be the 
drug of choice for severe or complicated enteritis (adult: 500mg b.i.d. for 5 days; 
children: 40mg/kg b.i.d. for 5 days). Despite decades of use, the rate of resistance of 




Until a few years ago, ciprofloxacin, a fluoroquinolone drug, was considered as 
another choice, especially for the treatment of traveler’s diarrhea.  Unlike erythromycin, a 
rapidly increasing proportion of Campylobacter strains all over the world have been 
found to be fluoroquinolone-resistant (83, 197, 205).  No surprisingly, this coincided with 
the approval and extension of the use of fluoroquinolones, such as enrofloxacin, in food 
animals in those countries (63).  In the United States, the prophylactic treatment of 
poultry with fluoroquinolones plays a critical role in the problem of increasing prevalence 
of ciprofloxacin-resistant Campylobacter isolated from humans and poultry.  The source 
of fluoroquinolone-resistant Campylobacter infections was the consumption of poultry 
colonized with resistant strains, rather than selection for Campylobacter resistance in the 
human gut after clinical treatment (102).  
 
Isolation and detection of Campylobacter 
According to USDA/FSIS/FDA-BAM, the isolation of Campylobacter from retail 
raw meat and poultry samples is always conducted under microaerophilic condition.  
Meat sample rinse solution is shaken overnight at 42ºC with selective enrichment Bolton 
Broth, and plated on modified Campy blood-free selective agar (MCCDA).  After 24-48 
h of incubation at 42ºC, suspected Campylobacter colonies, which have round, smooth 
with a defined edge to irregular spreading, thick to translucent, colorless to grayish 
appearance are identified by phase-contrast microscopy and biochemical test, including 
catalase and oxidase tests.  However, this kind of traditional cultural detection method is 




developed, such as DNA-DNA hybridization (46), species-specific polymerase chain 
reaction (PCR) (66), and real-time PCR (131, 232).  The antigens of the C. jejuni-C.coli 
group are heterogeneous and complex.  Serotyping methods for Campylobacter species 
are somewhat analogous to those for members of the family Enterobacteriaceae, which 
use tolerance to heat as a means to separate somatic, flagellar, and capsular antigens.  To 
standardize serotyping on an international basis, the International Committee on 
Serotyping Campylobacter recommended in 1985 that the systems of Penner (134) and 
Lior (140), which are based on two sets of standardized strains from geographically 
diverse areas, be adopted and referred to as the HS and HL systems, respectively.  
 
Campylobacter-host interaction 
A reasonable understanding of the general clinical, microbiological and 
epidemiological aspects of Campylobacter infection has been achieved since the selective 
growth media were developed in 1970s.  However the mechanisms involved in 
pathogenesis are still not well understood partially due to the lack of suitable in vivo 
models.  Based on clinical syndromes and experimental evidence, at least three 
mechanisms for gastrointestinal illness have been postulated: (i) intestinal colonization of 
ingested organisms and/or production of bacterial cytotoxin, inducing secretory diarrhea 
(51, 81, 106); (ii) bacterial invasion and proliferation within the intestinal epithelium 
(194, 231), causing cell damage and death, as well as inflammatory responses; and (iii) 
extraintestinal translocation (79, 127), in which the organisms cross the intestinal 




possible mechanisms are not mutually exclusive, and any combination may play a role in 
Campylobacter infection depending on the host status and attributes of the infecting 
strain (different pathotype). 
Bacterial diseases are typically the results of a complex set of interactions 
between the infecting bacteria and the defending host.  Here, an overview of the 
interaction of C. jejuni with host cells is given as below. 
Colonization and toxin production 
The first visible interaction between Campylobacter and its host entails 
colonization of the mucus barrier or attachment to the eukaryotic cell surface.  Since C. 
jejuni is part of the normal gut flora in many animals including avians, rodents and dogs, 
C. jejuni is certainly able to colonize the intestinal epithelium, which has also been 
demonstrated in many in vivo and in vitro studies (27, 64, 99, 104, 122, 170, 236).  Cell 
adherence is a distinctly different process from invasion.  The ability of C. jejuni to 
colonize the gastrointestinal tract by binding to epithelial cells has been proposed to be 
essential for disease production (136).  
Numerous studies have been performed to describe potential Campylobacter 
adhesins that mediate binding to host cells. Reported possible adhesins include outer 
membrane proteins (OMPs), flagella, and glycoproteins (68, 113, 149).  Also C. jejuni 
has been showed to bind to extracellular matrix components such as fibronectin, which is 
mediated by a conserved 37 kDa OMP, CadF (120).  Flagellum has been implicated as 




immotile bacteria and significant reduction in adhesion potential (171, 221).  Mutant 
deficient in glycosylation was severely affected in its ability to colonize chicks (113).  On 
the other hand, components in intestinal mucus may serve as important receptors for C. 
jejuni colonization.  But the data are limited and make interpretation difficult by the 
multiple adherence factors of Campylobacter (119). 
Cell adherence is not necessarily followed by cell invasion.  Microorganisms 
adhere to the mucosa in the proximal small intestine and elaborate a toxin, resulting in a 
watery diarrhea, which is common in Vibrio cholerae.  Infectious Campylobacter strains 
from patients with acute watery diarrhea, not other clinical syndromes produced 
cytotoxin (187), which supported that toxin production is a proposed mechanism in 
patients with watery diarrhea.  Although our knowledge of C. jejuni toxins is still very 
limited, our understanding of one Campylobacter cytotoxin, cytolethal distending toxin 
(CDT), has been dramatically improved in recent years.  CDT production was first 
observed by Anderson in a gastroenteritis associated E. coli strain in 1987 (13). In 1988, 
Johnson and Lior first reported CDT production by Campylobacter (105), which is a new 
heat-labile toxin cytolethal to CHO, Vero, Hela, and HEp-2 cells, termed a CLDT, and 
distinct from previously reported cytotoxin and cholera-like toxin.  Campylobacter 
CLDT was negative in adult rabbit ligated ileal loops, suckling mouse and rabbit skin 
tests, and only could be neutralized by homologous rabbit antiserum.  There was no 
correlation between CDT production and serotype or biotype or origin of the tested 
Campylobacter strains (105).  The CDT produced by C. jejuni was shown to affect F-




eukaryotic cells (225).  These activities of CDT suggest possible contribution of CDT to 
diarrhea disease.  However, the role of CDT in C. jejuni pathogenesis still has not been 
determined due to the lack of proper animal model. 
Invasion and inflammatory response 
Campylobacter are so-called invasive bacteria, which induce their own 
phagocytosis into cells that are normally nonphagocytic.  The results of both in vivo (16, 
17, 172, 194, 196) and in vitro (53, 65, 121) studies suggest that invasion is also a key 
component of Campylobacter pathogenesis.  
Functional flagella and motility are believed to be essential for the internalization 
of C. jejuni in vitro (79).  Either nonflagellated or nonmotile mutant of C. jejuni 
demonstrated markedly reduced levels of invasion into cultured cells (79).  
Campylobacter requires nascent bacterial protein synthesis to facilitate bacterial invasion 
(126).  Invasion was inhibited by 98% in the presence of rabbit antiserum raised against 
Campylobacter that was cultivated with INT407 cells (126).  However, the ability to 
invade and the efficiency of invasion appear to be strain and cell line dependent (65, 119, 
173, 187).  Clinical isolates tend to be more invasive than nonclinical strains (122) using 
HEp-2 cells and extensive in vitro passage reduces the invasiveness of isolates (17).  
Everest et al. (65) found a significant, but not complete, correlation between strains 
obtained from patients with colitis and non-inflammatory diarrhea with respect to 
invasion of both Caco-2 and Hela cells.  However, such correlation was not present in 




Campylobacter invade host cells, the results suggested that Campylobacter strains have 
different host cytoskeletal requirements (either microfilament (MF)-dependent or 
microtubule (MT)-dependent) for invasion depending on the bacterial strain and host cell 
used (121, 160, 173).  
Cell invasion is the primary mechanism of colon damage and diarrhea disease 
caused by C. jejuni, which was shown in infant Macaca mulatta model (196).  Clinical 
evidence also showed existence of intestinal epithelial invasion in cases with bloody 
mucus and inflammatory cells in the stool.  Bacterial epithelium invasion triggers host 
response to transform infected cells into strongly proinflammatory cells, which recruit 
acute inflammatory cells, primarily polymorphonuclear leukocytes (PMN), to the site. 
Interleukin-8 (IL-8) is one of the principal inflammatory mediators attracting and 
activating PMNs, neutrophils in particular (47, 94).  Recent study showed that many 
strains of Campylobacter can induce secretion of IL-8 by INT 407 cells (90).  The 
induction of IL-8 secretion required live cells of Campylobacter and appears to be 
associated with cell invasion (90) or cytolethal distending toxin (91).  However, similar 
response can be induced by killed Campylobacter as well as live bacteria and do not 
depend on CDT in THP-1, human monocytes (109).   
In addition to triggering IL-8 production and an acute inflammatory response, 
internalized C. jejuni can be maintained within endosomal vacuoles inside epithelial cells 
(53, 121, 196).  Intracellular bacterial numbers began to decrease after internalization in 




gentamicin in the culture medium after 21h and persisted at the high level for >96h (121).  
The intracellular survival time observed in vitro is considerable and would allow for 
translocation to occur. 
Intestinal translocation 
Bacterial translocation enables the movement of viable bacteria across the 
epithelial barrier, where further extraintestinal dissemination can occur.  Although animal 
models are necessary for studying intestinal translocation, polarized epithelial cell lines 
provide a simple and controlled experimental alternative to animal models.  Polarized 
human colon carcinoma cells with differentiated apical and basolateral surfaces separated 
by tight or occluding junctions show the structural resemblance to the naïve intestine. 
Campylobacter has been observed to translocate across a polarized epithelial cell 
monolayer (34, 127).  Different from Salmonella (71), C. jejuni can penetrate from the 
apical to the basolateral surface of polarized Caco-2 without a large scale loss in 
transepithelial electrical resistance (TER) (34, 127), which indicates the tight junction 
integrity.  The transepithelial route remains undefined.  Either transcellular pathway, or 
paracellular pathway or both routes that Campylobacter may take is strain-dependent (34, 
127).  Some strains also appear to transcytose without invasion (65) or have different 
rates of transepithelial trafficking (87).  However, the role of translocation in 






Molecular pathogenesis of Campylobacter 
The completion of C. jejuni NCTC11168 whole genome sequence is a landmark 
in understanding of Campylobacter pathogenesis (178).  During the last few years, 
research at the genome level opens the way for application of novel molecular 
techniques, like DNA microarray, resulting in novel and important insights into basic 
research on Campylobacter, a problematic pathogen with a small circular chromosome of 
1.6-1.7 megabases.  Genome-wide comparison showing gene diversity in C. jejuni is 
largely restricted to a small number of genomic regions, leaving large portions of genome 
stable (180, 212).  These plasticity regions include locus for flagellin modification, 
protein glycosylation, capsule biosynthesis, as well as LOS biosynthesis (180, 212).  The 
substantial progress in the understanding of virulence machinery of C. jejuni has been 
made and a detailed review follows. 
Flagella  
Campylobacter  jejuni contains one or bi-polar flagella that cause the typical 
darting motility, and give moist appearance to colonies on agar plates.  Like other 
bacteria, the flagellum assembly apparatus of C. jejuni is composed of a basal body, 
hook, and filament (Fig. I-1).  The flagella filament is composed of two proteins, encoded 
by flaA and flaB; however, flaA is more preferential and expressed at higher level than 
flaB, which is regulated by σ54 promoter, and subject to environmental regulation (11).  
Motility and expression of flaA gene are essential for colonization of animal and cause 




 Figure I-1. Model of C. jejuni flagellum apparatus and its regulation (229) 







Moreover, the expression of flaA gene is necessary for maximal invasion of eukaryotic 
cells and for the translocation of C. jejuni across polarized cells (79, 221).  The whole fla 
regulon in C. jejuni is regulated by FlgS/FlgR two component signal transduction system 
(229).  Phosphorylated FlgR is needed to activate RpoN-dependent genes of which the 
products form the flagellum complex (229).  flgS, flgR and rpoN are all early flagella 
genes and regulated by σ70, and their mutants are unflagellated (229).  FliD forms the cap 
structure at the tip of the external filament and plays essential role in polymerization of 
flagellin. FliD-defect mutant lacks flagella and is nonmotile (101).  Similarly, defect in 
nonfilament structural components, hook protein FlgE2 and basal body proteins FlgB and 
FlgC, failed to synthesize FlaA and exhibited nonmotile phenotype (125).  
Adhesion 
A variety of putative C. jejuni adhesins have been identified.  The C. jejuni 
genome sequence has clarified no pilus structures encoded on chromosome (178).  




protein CadF, encoded by cadF, is required for binding of C. jejuni to intestinal epithelial 
cells (160).  This interaction also involves host cell cytoskeleton polymerization and 
tyrosine phosphorylation signaling pathway, which promotes the internalization of C. 
jejuni (160).  PEB1(182), (a homolog of Gram-negative ABC transport systems, 
involving amino acid transport) is another putative major cell binding factor.  Recently, 
glycosylation system is implicated to be important for attachment to epithelial cells and 
colonization of chicks (113).  pglH mutant, deficient in ability to glycosylate a number of 
C. jejuni protein except LOS and capsule, had significantly reduced ability to adhere to 
the Caco-2 cells and severely affected ability to colonize chicks (113).  
Invasion 
The invasiveness of this organism has been studied in a variety of cell lines, 
including the intestinal epithelial-derived cell lines INT407 and Caco2.  Several new 
bacterial proteins have been shown to be required for invasion (126).  Secreted CiaB 
protein, with similarities to type III secreted proteins, was translocated into cytoplasm of 
the host cell, and its null mutant was deficient in the secretion of other proteins (123).  
Therefore, CiaB protein secretion required functional flagella export apparatus (125).  
Recent study described that another protein, FlaC, in C.jejuni TGH9011, is dominantly 
found in the extracellular milieu (208).   flaC mutant didn’t affect motility and flagellum 
morphology, but was deficient in invasion of Hep-2 cells.  Furthermore, flagella basal 
body gene flgF mutant or hook gene flgE mutant couldn’t secret FlaC (208).  All these 
indicated that FlaC is a protein secreted by flagella export apparatus and may play a role 




plasmid pVir in C. jejuni 81-176 (20), Type IV system, like cag pathogenicity island of 
Helicobacter pylori, is also used to inject bacterial protein into the cytosol of targeted 
cells by pathogens.  However, only 10% of 58 fresh clinical C. jejuni isolates harbor the 
pasmid-encoded VirB11 gene (20), and transfer of this plasmid to C. jejuni NCTC11168 
did not reproduce the same phenotype, which suggested that pVir is not responsible for 
all C. jejuni-induced pathogenic effect.  Recent report (217) supported that the pVir 
plasmid was significantly associated with the occurrence of blood in patient stool, a 
marker of invasive infection; but not associated with the greater occurrence of diarrhea, 
fever, pain, vomiting, or need for patient hospitalization, which in turn explained the low 
prevalence of the plasmid among strains. 
No consensus has been established on the host factors involved in Campylobacter 
invasion yet.  However, studies showed cytochalasin-D treated host cells dramatically 
decreased the number of Campylobacter internalization (122), suggesting actin 
polymerization is required for invasion.  While the opposite studies reported 
cytochalasin-D insensitive invasion, and no involvement of microfilaments, but 
microtubules (173).  Confusingly, there were reports on clathrin-independent endocytosis 
(228) and clathrin-coated pits (173) in C. jejuni invasion, as well as another controversial 
report showing no involvement of all previously indicated mechanisms in C. jejuni 







Historically, a variety of toxic activities have been attributed to C. jejuni.  
However, availability of genome sequence clarified cdt genes are the only identifiable 
toxin genes (178).  It is clear that CDT toxin is a tripartite holotoxin, with CdtB as the 
active moiety and CdtA and CdtC necessary for the delivery of the enzymatically active 
subunit (133).  CDT affected epithelial cells undergo cytodistension and cell cycle arrest 
in G2/M phase (132).  However, it is not yet clear what role CDT plays in Campylobacter 
infection in vivo.  
Surface structures 
All C. jejuni strains produce a surface-located glycolipid termed 
lipoologosaccharide (LOS), which has gained a lot attention due to a postulated role in 
the elicitation of GBS following C. jejuni infection.  Now it is clear that carbohydrate 
mimicry of [Galβ1-3GalNAcβ1-4 (NeuAcα2-3) Galβ1-] between C. jejuni LOS and 
human ganglioside GM1 causes GBS (233).  Molecular mimicry of ganglioside by LOS 
is in part dependent on the presence of N-acetylneuraminic acid (sialic acid) in both 
structures.  Sialic acid terminates oligosaccharide chains on mammalian and microbial 
cell surfaces through sialyltransferase Cstll, playing critical roles in recognition and 
adherence (45).  N-acetylneuraminic acid synthetase genes (neuA, neuB and neuC) 
involved in sialylation of LOS, and insertional mutagenesis of the neuB gene resulted in a 
LOS lacking N-acetylneuraminic acid (139).  It has been proposed that C. jejuni 
lipoologosaccharide is composed of two covalently linked domains: lipid A, a 




an outer core (15) (Fig. I-2).  Two outer core mutants, lacking N-acetylneuraminic acid 
and terminal N-acetylgalactosamine respectively, didn’t show any invasion deficiency 
(15), while a waaF mutant of C. jejuni 81-176, encoding heptosylthansferase II, involved 
in the addition of the second heptose displayed dramatic decrease in invasion of INT407 
cells (111).  
Figure I-2. Schematic showing the molecular structure of the LOS and highlighting the 
inner-core region. Hep, heptose; PEtn, phosphoethanolamine. Kdo, 3-deoxy-D-manno-2-
octulosonic acid (111) 
                                                  
The analysis of C. jejuni genome sequence identified a group of genes (kps) 
involved in capsular polysaccharide biosynthesis (178).  These genes located in one of 
the plasticity region of the chromosome (180) could serve as the molecular base of 
Penner serotyping and be involved in phase variation.  
Campylobacter-induced cell signaling pathways and chemokine induction 
Host cell signal transduction plays an important role in Campylobacter 
internalization.  Inhibitors of host protein tyrosine phosphorylation significantly reduced 
invasion of Caco-2 cells (228).  Biswas D et al (30) also reported that exposure of INT-
407 cells to protein kinase inhibitors resulted in decreased invasion of these cells by C. 
jejuni in a dose-dependent manner, suggesting that protein phosphorylation is a 




Infection by C. jejuni may lead to activation of the local immune response.  IL-8 
is a potent chemokine involved in neutrophil attraction and can be induced by C. jejuni 
(90, 91).   The early-response transcription factor NF-κB triggers the expression of genes 
associated with cellular immune and inflammatory responses.  Co-culture of Hela cells 
with viable C. jejuni lead to the activation of the transcription factor NF-κB (154), and a 
heat-stable cell free-extract of C. jejuni was reported to be able to activate NF-κB through 
IκBα degradation and DNA binding (154).  
 
In vitro cell culture methods for investigating Campylobacter pathogenesis  
Studying the mechanisms of Campylobacter pathogenesis is complicated by the 
lack of simple animal models that can mimic the disease seen in humans.  Different 
animal models have been tried to delineate the mechanisms of Campylobacter infection, 
including ferret (26, 27, 72, 85), hamster (4, 98), mice (24, 70, 209), rabbit (39, 40), 
guinea pig (211), pig (33, 142, 218), chicken (194, 198), and monkey (107).  However, 
Campylobacter only colonize chicken gut, but cannot cause infection; on the other hand, 
Campylobacter can cause much higher lethal rate, up to 53% (40), in rabbit model than in 
humans, which is only 0.05 per 1000 infections (8).  For other animal models, although 
they develop some similar disease process as seen in humans, like leukocytic filtration, 
diffuse edema, mild to moderate diarrhea etc., no correlation can be found in virulence, or 
no association between model animal virulence and other symptoms (24), or no antigen-
specific immune response can be detected (26, 72).  Recently, New World Monkey was 




monkey with C. jejuni causes dose-related diarrhea and robust immune response (107).  
This model may be helpful for studying anti-Campylobacter vaccine efficacy.  These 
animal models have been very useful in dissection the nature of host-bacterial interaction 
during infection.  However, there is still no simple animal model that can resemble the 
etiology, course, pathology, and immunology of Campylobacter infection in humans.  
Instead of animal model, in vitro cell culture methods provide a useful alternative to 
investigate the interactions between Campylobacter and the host epithelium during 
infection.  And no surprisingly, most our knowledge comes out from these experiments.  
Currently, studies on host-pathogen interactions in vitro usually use non-polarized 
epithelial culture.  And apparently, the use of non-polarized cell lines has become a 
standard approach for studying Campylobacter pathogenesis.  Different from unpolarized 
epithelium, polarized epithelial culture is actually the one that mimics the mucosal 
epithelium which is highly polarized with the apical membranes facing the luminal 
contents and basolateral membranes interfacing with the underlying cells in the lamina 
propria.  The apical and basolateral membranes are very biochemically distinct with 
respect to transport functions and cellular localization of surface components such as 
Toll-like receptors, which are type I transmembrane proteins that appear to respond to 
different stimuli (19, 76, 164).  Many pathogens have evolved different mechanisms to 
overcome epithelial barrier and establish infection (50).  These include disruption of 
epithelial barrier function, transcytosing from one membrane domain to the other, or 
inducing cell movement such as neutrophil recruitment.  When studying these processes 




humans and present a complex system in which many variables cannot be controlled.  
Therefore, in vitro transepithelial models that permit the study of a relevant biological 
surface have been developed, to integrate not only interactions between bacteria and 
epithelial cells but also, under certain conditions, to integrate a third cell type, such as 
neutrophils or dendritic cells.  Such models are particularly useful for studying the 
bacteria-host relationship as it would occur in the microenvironment of the human 
epithelium to enhance our understanding of the unique strategies by which pathogenic 
bacteria exploit host cells to overcome the initial epithelial hurdle (143).  
                                 
Choice of cultured epithelial cell line and multiplicity of infection 
The in vitro gentamicin resistance assay has been frequently used as a standard 
method to measure cell penetration by bacteria.  It is based on the principle that the 
aminoglycoside antibiotic gentamicin has a limited ability to penetrate eukaryotic cells.  
Internalized bacteria are thus protected and can be counted.  Use of the gentamicin 
resistance assay has shown that invasiveness varies considerably depending on the strain 
(29, 87), but other variables like epithelial cell line and multiplicity of infection as well.  
In vitro cell culture methods of measuring Campylobacter invasion have been 
done in a variety of cell lines with differing outcomes.  Cell lines of human intestinal 
epithelium origin are considered to be most appropriate for studying Campylobacter 
invasion (119), although HEp-2, Int 407, HeLa and Caco-2 cells are those most 




embryonic intestine and developed into their present epithelial phenotype after 60 
passages in culture (88).  The HEp-2 cell line came from tumors produced after injection 
of rats with epidermoid carcinoma tissue.  Both Int 407 and HEp-2 cell lines have no 
difference from the Human Negroid cervix epithelioid carcinoma cell line HeLa and be 
considered as derivatives of HeLa.  Caco-2 cell line is a human colon adenocarcinoma 
that can differentiated into columnar cell monolayer on Transwell filter inserts with 
enterocytic morphology characterized by the formation of a brush border containing 
numerous microvilli, the presence of occluding junctions exclusively at the apical surface 
and a tall, more compact cell shape (92).  Although similar characteristics have been 
observed for plastic-grown cells, the support medium and coating may cause Caco-2 cells 
to exhibit different features (56).  T84 cell line is also a human colon adenocarcinoma 
that has been well characterized for use a model system for intestinal epithelial transport 
(Fig. I-3).  It has been widely used for studying other enteric pathogenic bacteria (78, 95, 
144, 146, 185) although not so popular in Campylobacter (159).  And another advantage 
of T84 cell is that it has been well documented for Toll-like Receptors (TLRs) 
expressions, locations on cell surface and their trafficking pathway as well (41, 42, 89, 
155).  Anyway, it is important to understand the implications of using variable cell types 
for in vitro studies such as the gentamicin resistance assay.  The state of epithelial cell 
growth and differentiation at the time of bacterial inoculation will also differ depending 
on the length of the culturing period post seeding.  The resulting cell types may harbor 
different bacterial receptors or adopt different mechanisms required for bacterial 




Figure I-3.  In vitro T84 transepithelial cell model 
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Campylobacter spp. in food is essentially the same as that for Salmonella spp. in raw 
meat and poultry.  Basic and applied research on Campylobacter spp. has been, and is 
being conducted in a large extent to better understand and control Campylobacter spp. in 
food-producing animals, which appear to be the major reservoir.  The major goal of this 
study is to determine the pathogenicity of C. jejuni/coli isolated from chicken meat 
products and identify the genes that are involved in. 
Objectives of the project are: 
1) To determine the abilities of various C. jejuni/coli retail meat isolates to 
adhere to, and invade the intestinal epithelial monolayer. 
2) To identify the genes differentially expressed in C. jejuni/coli strains during 
their interaction with host epithelial cells. 
3) To examine the abilities of C. jejuni/coli-host epithelial cell interaction to 
induce proinflammatory interleukin-8 secretion and to explore its mechanism. 
In the following chapters (II, III, and IV), three studies are presented that were 
conducted to fulfill the goal of this project.  Firstly, gentamicin resistance assay were 
applied to determine the adherence and invasiveness of the Campylobacter retail meat 
isolates in vitro; secondly, differential display was used to identify the genes 
differentially expressed in C. jejuni strain during the bacteria-host cell interaction; and 
thirdly, enzyme linked immunosorbent assay (ELISA) for IL-8 and Western-blot were 
taken to examine the proinflammatory IL-8 secretion abilities among Campylobacter 




CHAPTER II:  ADHERENCE AND INVASION OF 
CAMPYLOBACTER JEJUNI/COLI ISOLATED FROM RETAIL 




The abilities of 34 Campylobacter jejuni and 9 Campylobacter coli isolates 
recovered from retail meats to adhere to and invade human intestinal epithelial T84 cells 
were examined and compared with a well-characterized human clinical strain, C. jejuni 
81-176, in order to better assess their pathogenic potential.  These Campylobacter retail 
meat isolates exhibited a wide range of adherence and invasion abilities with a few of the 
isolates adhering to and invading into T84 cells at levels close to those of C. jejuni 81-
176.  There was a significant correlation between the adherence and invasion abilities of 
the Campylobacter isolates.  The presence of eight putative virulence genes that are 
potentially responsible for adherence and invasion, or encode cytolethal distending toxin 
in the Campylobacter isolates was determined using PCR.  All Campylobacter isolates 
possessed flaA, cadF, pldA, cdtA, cdtB, and cdtC, and most (91%) also contained ciaB 
gene.  However, virB11 gene, carried by a virulence plasmid pVir, was absent in almost 
all the Campylobacter isolates.  Our findings indicated that C. jejuni and C. coli present 
in retail meat were considerably diverse in their ability to adhere to and invade human 
intestinal epithelial cells, and that the putative virulence genes were widespread among 
the Campylobacter isolates.  This suggests that despite of the presence of the putative 
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virulence genes, only some, but not all, Campylobacter strains isolated from retail meat 
can effectively invade human intestinal epithelial cells in vitro. 
 
INTRODUCTION 
Campylobacter is one of the leading causes of acute bacterial diarrhea worldwide 
(150).  Numerous surveys have revealed retail meat and raw milk as sources of human 
infection (12).  Particularly, a high percentage of poultry products is contaminated with 
Campylobacter (74, 163, 235).   
A general body of knowledge that has been developed thus far regarding the 
pathogenicity of Campylobacter indicates that the organisms cause disease by at least 
three mechanisms: (i) intestinal colonization of ingested organisms, and production of 
bacterial cytotoxin (51, 81, 106), inducing diarrhea, (ii) bacterial invasion (194, 231), 
causing damage to mucosal surface cells of jejunum, ileum and colon, and (iii) 
extraintestinal translocation (79, 127), in which the organisms cross the intestinal 
epithelium and migrate via the lymphatic system to various extraintestinal sites. These 
possible mechanisms are not mutually exclusive, and Campylobacter may make use of 
any combination of the mechanisms depending on the host status and attributes of the 
infection strain.  The molecular basis of pathogenicity of Campylobacter has not been 
fully elucidated.  Several virulence factors, however, have been identified based on in 
vitro (53, 65, 122, 193) and in vivo (31, 196, 237) studies.  For example, flaA, encoding 
flagellin (221), and cadF, encoding a protein that interacts with a host extracellular 
matrix protein fibronectin (160), have been shown to be required for Campylobacter 
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adherence and colonization to the host cell surface. Other genes including ciaB (124, 
189), pldA (189), and genes of pVir plasmid (21) are involved in host cell invasion.  The 
genes of cdtA, cdtB and cdtC (133, 188) are responsible for the expression of 
Campylobacter cytolethal distending toxin (CDT), which induces the proinflammatory 
cytokine production of epithelial cells (91) and causes host cell cycle arrest, cell 
distention and eventually cells death (225).  
The ability of C. jejuni to adhere to and invade the epithelial cells of the 
gastrointestinal tract is important for the development of Campylobacter-mediated 
enteritis (183, 196).  The adherence and invasion of C. jejuni to host cells has been 
studied using a variety of cell lines (54, 97, 119, 173).  Human colonic epithelial cell line 
T84 has been widely used to assess the ability of enteric bacteria to adhere to and invade 
the epithelium.  C. jejuni strain 81-176, a well-studied human clinical strain (128), has 
been demonstrated to have a relatively high invasion efficiency to several human 
intestinal epithelial cell lines, including T84 (97, 173), and to cause illness in human 
volunteers (31).   
Despite frequent contamination of retail meat with Campylobacter, it remains 
unclear whether all Campylobacter in retail meat are pathogenic to humans and which 
factors specifically contribute to their pathogenicity.  Methodologies on specifically 
identifying and distinguishing pathogenic strains of Campylobacter from non-pathogenic 
ones are needed for food safety surveillance.  The present study was undertaken to 
characterize the adherence and invasion abilities of Campylobacter isolated from retail 
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meat using the T84 cell culture model and determine the prevalence of eight putative 
virulence genes in these isolates. 
MATERIALS AND METHODS 
Bacterial strains.  Forty-three Campylobacter (34 C. jejuni and 9 C. coli) isolates 
were selected based on their distinct DNA fingerprinting profiles of pulsed-field gel 
electrophoresis (PFGE) (Fig.II-1) from 378 Campylobacter isolates that were recovered 
from retail raw meats collected in the Washington, D.C. area from June 1999 to July 
2000 (235). The 43 isolates were recovered from chicken (n=36), turkey (n=4), pork 
(n=2), and beef (n=1) samples.  The isolates had undergone two passages before used for 
the analyses.  A well-characterized human clinical strain, C. jejuni 81-176 (kindly 
provided by Dr. P. Guerry-Kopecko at Naval Medical Research Center, Bethesda, MD) 
(82, 171), and a noninvasive E. coli laboratory strain, DH5α, were used as positive and 
negative controls for all the analyses, respectively.  
 
Bacterial growth conditions.  Campylobacter bacteria were routinely grown on 
Mueller-Hinton (MH) agar (Difco Lab, Livonia MI) containing 5% (v/v) citrated sheep 
blood at 37 °C under a microaerophilic atmosphere (85% N2, 10% CO2, and 5% O2).  E. 
coli DH5α was cultured aerobically on Luria-Bertani (LB) agar (Sigma, St Louis, MO) at 
37 °C.  All bacteria were subcultured for 18 h before used in experimental assays.  The 
bacteria were harvested from the plates with phosphate-buffered saline (0.01 M sodium 
phosphate, pH 7.4, and 0.15 M NaCl) and diluted to a concentration of ~108 CFU/ml, 
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which was determined using a spectrophotometer (SmartSpecTM 3000; BioRad, Hercules, 
CA) at a wavelength of 600 nm.  Titration and serial dilution analyses showed that an 
absorbance of 0.1 corresponded to 4.09×108 CFU/ml Campylobacter bacteria.  
 
Cell culture.  T84 cells (human colonic epithelial cell line, ATCC CCL-248) 
were cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 
medium containing 1.2 g/L sodium bicarbonate, 2.5 mM L-glutamine, 15 mM HEPES 
and 0.5 mM sodium pyruvate (Invitrogen, San Diego, CA) supplemented with 5% (v/v) 
fetal bovine serum, penicillin and streptomycin (5% DME/F12), as recommended by the 
American Type Culture Collection.  Cells were seeded onto 24-well tissue culture plates 
(Costar, Cambridge, MA) at 2×105 cells/well and grown for 24 h under 5% CO2 at 37 °C 
before adherence and invasion assays. 
 
Adherence and invasion assay.  The adherence and invasion assays were 
performed using T84 cells cultured in 24-well tissue culture plates as previously 
described (119). T84 cells were rinsed five times with prewarmed invasion media (5% 
DME/F12 without penicillin and streptomycin) and inoculated with 106 CFU bacteria in 1 
ml invasion medium per well, with the multiplicity of infection (MOI) about 10-20.  The 
number of inoculated bacteria was determined simultaneously on MH-blood agar plates.  
T84 cells were incubated with bacteria for 3 h in a humidified, 5% CO2 incubator at 37 
°C to allow bacteria to adhere and invade.  The cells were then washed five times with 
PBS to remove bacteria that have not yet adhered and lysed with 1% saponin (Sigma) for 
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5 min to release cell-associated bacteria.  Serial dilutions of the lysates were plated on 
MH-blood agar plates.  After incubation at 37 °C for 48 h, Campylobacter colonies on 
MH-blood agar plates were enumerated to determine the number of cell-associated 
bacteria.  
To determine the number of bacteria that had been internalized, T84 cells that 
were incubated for 3 h with bacteria were washed three times with PBS and incubated for 
an additional 2 h with 5% DME/F12 containing 100 µg/ml gentamicin (Sigma) to kill 
extracellular bacteria.  After incubation, cells were washed three times with PBS to 
remove gentamicin and lysed with 1% saponin to release intracellular bacteria.  The serial 
dilutions of the lysates were plated on MH-blood agar plates.  The number of CFU on 
MH-blood agar plates was counted as the number of bacteria invaded into T84 cells.  
Each assay was performed in triplicate wells and repeated at least three times.  The 
number of adhered or internalized bacteria was plotted as a percentage of the starting 
viable inoculum.  Control studies were conducted to verify that a 2-h exposure of the 43 
Campylobacter isolates to 100 µg/ml of gentamicin resulted in 100% killing (data not 
shown).  Time course analyses (0 to 4 h) were carried out to determine the optimal length 
of time for the incubation of T84 cells with Campylobacter (data not shown).  
The correlation between the abilities of the Campylobacter isolates to adhere to 
and invade into T84 cells was analyzed by linear regression using SPSS 10.0 version 




Detection of virulence genes.  PCR was used to detect eight Campylobacter 
genes that are associated with virulence in the genomic and plasmid DNA of the 
Campylobacter isolates.  The eight genes include flaA, cadF, ciaB, pldA, virB11, cdtA, 
cdtB, and cdtC.  PCR primers specific for these genes were designed based on the gene 
sequence information of GeneBank database and previous published studies (Table II-1).  
Conserved sequences of each gene were selected.  Two different primer sets were used 
for each gene.  Template DNAs for PCR were extracted by a boiling method described 
previously (157). Fresh cultures of Campylobacter isolates and the negative control strain 
(E. coli DH5α) were suspended in 1 ml saline and boiled at 100 °C for 10 min.  After 
centrifugation at 14,000×g for 2 min, the supernatants were collected and stored at –20 
°C until use.  For detecting virB11, both genomic DNA and plasmid DNA from each 
Campylobacter isolate were used as PCR templates.  PCR was carried out using 
AmpliTaq Gold polymerase (Roche Molecular Biochemicals, Mannheim, Germany) with 
30 cycles of amplification in a GeneAmp PCR system 9600 thermocycler (Perkin-Elmer, 
Foster City, CA).  The cycling program included denaturation at 94 °C for 1 min, 
annealing at a temperature specific to each primer pair for 45 s, and extension at 72 oC for 
45 s. PCR products were analyzed by 2% agarose gels, stained with ethidium bromide, 








The adherence and invasion abilities of Campylobacter retail meat isolates.
 To test the pathogenic property of Campylobacter retail meat isolates, the 
adherence and invasion abilities of 43 Campylobacter isolates from retail raw chicken, 
turkey, beef and pork to human intestinal epithelial cells T84 were analyzed using 
gentamicin resistant assay (119).  Fig. II-2A shows the adherence and invasion abilities 
of each isolate, and Fig. II-3 displays the distribution of the adherence and invasion 
abilities of 43 Campylobacter raw meat isolates tested.  After a 3-h incubation, the 43 
Campylobacter isolates adhered to T84 cells at a range of 0.002-3.115% of the starting 
viable inoculum (Fig. II-2A), compared to 1.790% adherence level of the positive control 
strain C. jejuni 81-176.  A half of the isolates adhered to the cells at levels ranging from 
0.002 to 0.170%, which are less than one tenth of that of C. jejuni 81-176, whereas five 
isolates (12%) adhered to the cells at levels ranging from 0.590 to 3.115% (Fig. II-3), 
which are close to that of C. jejuni 81-176.  One of the isolates from a chicken meat 
sample, C. coli C54, showed the greatest adherent ability among all strains tested.  Its 
adherent level (3.115%) was even greater than that of C. jejuni 81-176 (1.790%).  No 
significant difference (p>0.05) between C. jejuni and C. coli strains in their abilities of 
adherence to T84 cells was detected.  The non-pathogenic E. coli DH5α also showed a 
high level of adherence, similar to C. coli C54.  This suggests that a high adherent ability 
of bacteria to host epithelium does not necessarily lead to infection.  
After a 3-h incubation, the percentages of the Campylobacter isolates resistant to 
extracellular gentamicin treatment were found to be in the range of 0.001-0.235% of the 
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starting viable inoculum (Fig. II-2A).  The invasion abilities of the 43 raw meat isolates 
were all lower than that of C. jejuni 81-176 (0.315%).  Among the 43 meat isolates, 18 
isolates (42%) showed invasion levels below 0.004%, which was similar to that of the 
non-invasive negative control E. coli DH5α (0.001%), but much lower than that of C. 
jejuni 81-176.  All of the four turkey isolates belonged to this group.  Six raw meat 
isolates had the invasion levels above 0.040%, within one tenth of the invasion level of C. 
jejuni 81-176.  The remaining 19 isolates (56%) had invasion levels between 0.004% and 
0.040% (Fig. II-2A).  C. coli C54, which was isolated from a chicken sample, had the 
highest level of invasion (0.235%) among the strains tested, similar to that of C. jejuni 
81-176 (0.315%).  Compared to C. jejuni, C. coli isolates demonstrated a similar range of 
invasion levels, however, six out of nine C. coli isolates tested showed invasion levels 
lower than 0.004%.  These results indicate that the abilities of Campylobacter meat 
isolates to adhere to and invade T84 cells vary in a wide range, and only a low percentage 
of the isolates have the adherence and invasion levels similar to the well-characterized 
human clinical strain C. jejuni 81-176.  
 
Correlation between the adherence and invasion abilities of Campylobacter 
retail meat isolates. To test the interrelationship between Campylobacter adherence 
and invasion events, we determined the correlation coefficient between the 
Campylobacter adherence and invasion variables using the method of linear regression 
(Fig. II-4).  The correlation coefficient (r) between the adherence and invasion efficiency 
of the Campylobacter retail meat isolates was found to be 0.543 with P<0.01, indicating a 
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significantly positive relationship between the invasion and adherence variables.  
However, there were a few exceptions.  Campylobacter isolates C114, J385, and C49 
showed strong adherence but poor invasion abilities, whereas J237, J5 and J57 exhibited 
relatively low adherence but moderate invasion abilities.  This suggests that the invasion 
abilities of Campylobacter retail meat isolates be associated with their adherent abilities, 
but the adherence of Campylobacter to the host epithelium does not necessarily lead to 
invasion. 
 
Presence of the putative virulence genes. Even though the genes that 
determine the infectivity of Campylobacter have not been well studied, several genes 
have been found to be involved in Campylobacter adherence and invasion of host cells.  
To test whether the relative adherence and invasion levels of the Campylobacter isolates 
are related to the presence of particular virulence genes, the presence of eight putative 
virulence genes in the genomic and plasmid DNA of the 43 retail meat isolates were 
determined by PCR using two different pairs of primers for each gene (Table II-1).  As 
showed in Fig. 1B, the majority of the Campylobacter isolates possessed seven of the 
eight virulence genes examined, including flaA (100%), cdtA (100%), cdtB (100%), cdtC 
(100%), ciaB (91%), cadF (100%) and pldA (100%).  However, virB11 gene of pVir 
plasmid was not detected in most of the isolates except for chicken meat isolate C114 
(Fig. II-2B).  All eight virulence genes were detected in positive control strain C. jejuni 
81-176.  Genes cdtA, cdtC, cadF and pldA in some of these isolates were detected by 
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only one of the two pairs of primers used (Fig. II-2B).  This may be due to variability and 




Campylobacter is one of the major food-borne pathogens and widely spread in 
retail meat, in particular the poultry products.  However, little is known about the 
pathogenicity of these food-contaminating strains and the molecular basis of 
Campylobacter pathogenicity.  In this study, we examined the ability of Campylobacter 
strains isolated from raw meat products to adhere to and invade human intestinal 
epithelial line T84 cells, and determined the association between the presence of certain 
virulence genes and the adherence and invasion abilities of Campylobacter isolates from 
retail meats.  Our results revealed that Campylobacter strains with adherence and 
invasion abilities similar to those of the human clinical strain C. jejuni 81-176 were 
present in retail meat.  We found that 6 out of 43 tested isolates had invasion abilities 
close to C. jejuni 81-176, which is similar to a recent report that 12 of the 42 isolates 
from fecal samples of food and companion animals and beef carcasses were capable of 
invading epithelial cells (137).  The adherence and invasion abilities of the retail meat 
isolates varied considerably, from levels similar to that of C. jejuni 81-176 to levels 
thousand fold lower than that of C. jejuni 81-176.  However, more than half of the retail 
meat isolates tested exhibited the invasion efficiency 100 fold lower than that of C. jejuni 
81-176, indicating that not all Campylobacter strains that contaminate meat products are 
able to effectively invade human intestinal epithelial cells. 
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Because animal models that completely mimic Campylobacter infections in 
humans are not available, the cell culture model using human colonic epithelial cells 
provides us a useful tool to evaluate the abilities of Campylobacter food isolates to 
adhere to and invade the human intestinal epithelium.  In particular, T84 cell line has 
been widely used for studies of pathogenicity of many human enteric pathogens, 
including Salmonella typhimurium, Helicobacter pylori, and enteropathogenic E. coli (49, 
144, 167).  Even though the process of Campylobacter adhering to and invading into 
human intestinal epithelial cells T84 in culture does not exactly mimic the process in vivo, 
the cell culture model allowed us to determine the relative adherence and invasion 
abilities of the retail meat isolates in comparison to the well studied human clinical strain 
C. jejuni 81-176.  To ensure that the cell culture model was functioning properly, we 
carried out inoculation dose and time course studies (data not shown).  These studies 
showed that the binding of C. jejuni to T84 cells was time-dependent and saturable.  Even 
though MOI about 10  instead of 100 was used in this study the invasion and adherence 
levels of the human clinical strain C. jejuni 81-176 reported here are similar to previously 
published studies (119), (159, 195).  
Colonization or adherence of microbial pathogens to mucosal surfaces is the 
primary step of infection and appears to be a prerequisite for invasion in most cases (9, 
116, 117, 227).  In this study, we analyzed the interrelationship between adhesion 
efficiency and invasion efficiency of Campylobacter retail meat isolates by statistical 
analyses.  A positive correlation between the adhesion and invasion events was observed, 
which suggests that host invasion efficiency of Campylobacter is at least partially 
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dependent on its adherence ability.  Interestingly, not all of the tested strains agreed to 
this correlation.  Some of the isolates that adhered to T84 cells efficiently invaded T84 
cells poorly.  This suggests that the adherence of Campylobacter to host cells facilitate its 
invasion into host cells, but adherence itself does not necessarily lead to invasion. 
  It has been generally accepted that bacterial virulence is multi-factorial and 
determined by the expression of virulence genes.  To determine the interrelationship 
between the abilities of Campylobacter retail meat isolates to adhere/invade human 
intestinal epithelial cells and virulence genes that they carry, the prevalence of the 
putative virulence genes flaA, cadF, ciaB, pldA and virB11 and toxin genes cdtA, cdtB, 
cdtC among the 43 Campylobacter retail meat isolates was determined by PCR.  Even 
though the CDT has not been shown to be directly involved in host epithelial invasion, its 
role in inducing proinflammatory cytokine secretion of host epithelial cells (91) and 
inhibiting cell cycles (225) could influence the invasion and adherence ability of 
Campylobacter.  Using two different pairs of PCR primers that target conserved 
sequences for each gene, we were able to detect six out of the eight putative virulence 
genes in all of the 43 Campylobacter isolates.  The gene of ciaB was undetectable in four 
isolates with very low invasion ability.  In some of the retail meat isolates, the putative 
virulence genes were detected with one of the two PCR primer sets used, suggesting the 
presence of variability and/or random mutations in these genes.  The high prevalence of 
these genes in Campylobacter retail meat isolates with wide ranges of adherence and 
invasion efficiency may also suggest that additional genes be involved in the process.  
Our finding is consistent with previous studies that showed the high prevalence of the 
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same seven putative virulence genes in Campylobacter strains isolated from Danish 
turkeys, pigs and cattle (22, 23).  In addition to C. jejuni 81-176, only one of the 43 retail 
meat isolates, which had an invasion ability thousand times lower than C. jejuni 81-176, 
was positive for virB11 gene.  Bang et al. (22, 23) also reported a relatively low 
prevalence for virB11 gene in Campylobacter isolates compared to the prevalence of 
other putative virulence genes tested.  The prevalence of virB11 among the food isolates 
has not been well studied.  Our study did not find a general correlation between the 
invasion efficiency of Campylobacter retail meat isolates and the putative virulence 
genes present in their genomic DNA.  There are several possible explanations.  First, 
even though some of the low invasive strains contain most of virulence genes in their 
genome, they may fail to express these genes when they interact with host cells or they 
may express inactive variants of the virulence genes.  Secondly, virulence genes may 
have redundant and overlapping functions, thus missing one or two of these genes may 
not significantly affect the invasion ability of Campylobacter.  Thirdly, besides these 
eight virulence genes, additional genes are required for host invasion.  Further studies 
using the approaches of DNA microarray and mutagenesis are required to identify 
additional virulence genes of Campylobacter, determine which virulence genes are 
expressed upon host cell contact, examine the variability of virulence genes, and explore 




Table II-1. Campylobacter virulence genes and primer sequences for PCR identification. 
Target 
gene 





cadF-278 ATGGTTTAGCAGGTGGAGGA C. jejuni 
cadF cadF-510 GAGCTGGACGAGTATCAGCA 
252 















cdtA-284 TCCTTTGGGGCGTTCATTTG cdtA 
cdtA-798 ACCGCTGTATTGCTCATAGG 
534 
cdtB-1094 TCATCCGCAGCCACAGAAAG cdtB 
cdtB-1277 ACCCTATCAGGCCTTGAAAG 
203 


























pldA-361 AAGAGTGAGGCGAAATTCCA C. jejuni 
pldA pldA-726 GCAAGATGGCAGGATTATCA 
385 
pldA-539 GCTTATAGTTTTGGCTCATTAG C. coli 
pldA pldA-1154 TACAACAAACGCTTACAAAGAC 
637 





























Figure II-1. SmaI-digestion patterns of the Campylobacter retail meat isolates tested in 
this study.  Genomic DNAs were digested with SmaI and analyzed by pulsed-field gel 




Figure II-2. The ability of Campylobacter retail meat isolates to adhere to and invade human 
intestinal epithelial cells T84 and the distribution of virulence genes among these isolates. (A) 
Forty-three of Campylobacter strains isolated from retail chickens, turkey (*), pork (†), beef 
(‡), and the humans clinical isolate C. jejuni 81-176 were tested for their abilities to adhere to 
and invade into T84 cells using a gentamicin resistant assay (119).  The data were plotted as 
percentages of the starting viable inoculum. Shown are the means of percentages of cell 
(±S.D.) associated and involved in invasion based on three independent experiments.  (B) The 
presence of putative virulence genes, flaA, cadF, ciaB, pldA, virB11, cdtA, cdtB, and cdtC in 
the genomes and plasmids of different Campylobacter isolates was detected by PCR using 
two different pairs of primers for each gene.  The * indicates genes that were detected by only 
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Figure II-3. Distribution of adherence and invasion abilities among 43 Campylobacter 
strains isolated from retail meat.  The experiments were performed as described in Figure 
1A.  The adherence (A) and invasion efficiency (B) of Campylobacter retail meat 
isolates was expressed as percentages of the starting viable inoculum and plotted as the 













































































Figure II-4. The correlation between the invasion and adherence abilities of 43 
Campylobacter strains from retail meat.  The correlation between the invasion and 
adherence abilities of Campylobacter isolates as analyzed by linear regression using 
SPSS 10.0 version software.  Shown is the plot of -log (invasion %) versus -log 
(adherence %) of each strain.  The central line represents regression line [-
log(adhesion%)] =0.06+0.45*[-log(invasion%)]; the inner sidelines near the central line 
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CHAPTER III.  IDENTIFICATION OF COLONIZATION AND 
INVASION-RELATED GENES IN CAMPYLOBACTER JEJUNI BY 




Campylobacter jejuni is considered as an invasive bacterium, which is the most 
common bacterial cause of foodborne diarrhea illness worldwide.  In vitro cell culture 
model gives useful information on the potential role of different genes in pathogenesis. 
Gene expression in Campylobacter jejuni 81-176 during infection was compared to the 
expression of the control strain by restriction fragment differential display PCR (RFDD-
PCR).  This method amplifies cDNA restriction fragments under stringent PCR 
conditions, enabled by the use of specific primers complementary to ligated adaptor 
sequences.  Total twenty gene fragments having increased expression in T84-associated 
C. jejuni 81-176 were identified.  All these fragments had homology to stable bacterial 
ribosomal RNAs, which means false positives.  However, this study may provide some 
useful information for future prokaryotic gene expression analysis during host pathogen 
interaction based on no such report on Campylobacter host cell interaction studying yet, 








Campylobacter jejuni is one of the most common causes of human acute bacterial 
enteritis in industrialized countries.  Human campylobacteriosis is considered primarily a 
food-borne disease.  C. jejuni is a common gut commensal in most food producing 
animals and birds, and fecal contamination of meat during processing is a well-
recognized route of transmission to humans.  In contrast to Salmonella spp., 
Campylobacter spp. does not grow or compete well with other bacteria at common food 
abuse temperatures.  And it appears that the level of Campylobacter spp. in contaminated 
foods is governed only by the extent of initial contamination and that temperature abuse 
is not a significant factor.  However, the mechanisms by which C. jejuni colonizes and 
invades the intestinal tract after consumption and the genes that are involved in the 
processes are poorly understood.  In vitro cell culture model have enabled some invasion 
factors to be identified by using different mutants; these factors include flagellin (171, 
221), fibronectin-binding protein CadF (159), Campylobacter-invasion antigen Cia (190), 
and cytolethal distending toxin CDT (188).  However, such studies are highly dependent 
on the presumed properties of genes and thus do not generally lead to the identification of 
C. jejuni-specific colonization and invasion factors. 
The ability to define genes that may be expressed differentially during 
colonization and invasion will allow the molecular mechanisms of host-pathogen 
interaction to be elucidated.  Two approaches at the RNA level are currently applicable: 1) 
methods that select genes based on their differential expression under varying conditions 
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(during colonization and invasion or not), such as RAP-PCR (141) (219) or cDNA 
subtraction hybridization and differential library screens (179); 2) to define expression 
patterns of sequence-defined genes by mRNA analysis by northern hybridization, 
ribonuclease protection or RT-PCR. The availability of entire genome sequence of C. 
jejuni (178) makes any gene in theory may be investigated for expression by mRNA 
analysis.  
Differential display (DD) technique was developed in the early 1990s for 
eukaryotic cell study by integrating two of the most simple, powerful and commonly used 
molecular biological methods; namely, PCR and DNA sequencing by gel electrophoresis 
(138).  Numerous applications have been done for the identification of differentially 
expressed genes.   Unlike microarray, DD does not require any previous knowledge of 
mRNA or gene sequences, making it an ‘open’ system that is applicable to any 
eukaryotic organism.  However, some of the limitations in DD-PCR, such as the 
restriction to visualization of the 3’ end of the transcripts only, low annealing temperature 
during PCR amplification and a high number of false positive (55), have encouraged the 
development of new and improved techniques.  Furthermore, the original method 
displays polyadenylated transcripts and can therefore only be applied to eukaryotic RNA.  
Welsh and McClelland (224) reported a related method known as RNA arbitrarily primed 
PCR (RAP-PCR) using only primers of random sequence (44, 80, 220). Bachem (18) 
made a further improvement to use differential display technique based on cDNA 
amplified fragment length polymorphism (AFLP). Another DD variant method is 
developed as so-called restriction fragment differential display PCR (RFDD-PCR) (80). 
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The technology is based on digesting cDNA with endonucleases followed by adaptor 
ligation and PCR amplification with specific primers at high-stringency PCR 
amplification conditions. Thus the method can be equally applied to both eukaryotic and 
prokaryotic system. But so far, no application in related bacteria-host cell interaction 
study has been reported yet, especially on Campylobacter. This study may provide useful 
information on application of differential display technology in Campylobacter-host cell 
interaction study.  
 
MATERIALS AND METHODS 
Bacterial strain and growth conditions.  Campylobacter jejuni 81-176 was 
kindly provided by Dr. P. Gurry-Kopecko, from Naval Medical Research Center, 
Bethesda, MD.  It was routinely grown on Mueller-Hinton (MH) agar (Difco Lab, 
Detroit, MI) containing 5% (v/v) citrated sheep blood at 37 °C under a microaerophilic 
atmosphere (85% N2, 10% CO2, and 5% O2),  and subcultured for 18 h before used in 
experimental assays.  The bacteria cells were harvested from the plates with phosphate-
buffered saline (PBS; Difco) and diluted to a concentration of ~1.2×109 CFU/ml, which 
was determined using a spectrophotometer (SmartSpecTM 3000; BioRad, Hercules, CA) 
at a wavelength of 600 nm.  Titration and serial dilution analyses showed that an 




Cell culture.  T84 cells (human colonic epithelial cell line, ATCC CCL-248) 
were cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 
medium containing 1.2 g/L sodium bicarbonate, 2.5 mM L-glutamine, 15 mM HEPES 
and 0.5 mM sodium pyruvate (Invitrogen, San Diego, CA) supplemented with 5% (v/v) 
fetal bovine serum, penicillin and streptomycin (5% DME/F12), as recommended by the 
American Type Culture Collection (ATCC).  Cells were seeded into T-75 flask (Costar, 
Cambridge, MA) at 2.4×106 cells/ml and grown for 24 h under 5% CO2 at 37 °C before 
experiment. 
 
Infection protocol.  T84 cells were rinsed five times with prewarmed invasion 
media (5% DME/F12 without penicillin and streptomycin) and inoculated with ~1.2×109 
CFU bacteria in 1 ml invasion medium per flask, with the multiplicity of infection (MOI) 
about 500.  The number of inoculated bacteria was determined simultaneously on MH-
blood agar plates.  T84 cells were incubated with bacteria for 4 h in a humidified, 5% 
CO2 incubator at 37 °C to allow bacteria to adhere and invade.  
 
Isolation of bacterial and cellular total RNA.  Bacterial cells were washed four 
times with chilled 1× PBS to remove those that were not yet adhered, and 5 ml filter-
sterilized 2% saponin / RNAlater (1:1 volume ratio) was added to allow cell lysis for 5 
min to release host cell-associated bacteria and stabilize bacteria RNA at the same time. 
After vigorously vortexing, cell debris was removed by centrifugation for 4 min at 300×g, 
4 °C. The rest of cell lysate was pelleted at 9000 ×g, 4 °C for 10 min. The cell pellets 
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were resuspended in 100 µl of lysozyme-containing TE buffer (1mg/ml) by vortexing and 
incubated for 5 min at RT. Bacterial and cellular total RNA were isolated using RNeasy 
Mini kit (Qiagen Inc., Valencia, CA), and contaminated DNA was removed by on-
column DNase digestion kit (Qiagen Inc., Valencia, CA).  The quality and quantity of 
total RNA were assessed by Nanodrop, ND-1000 spectrophotometer (Nanodrop 
Technologies, Inc., Wilmington, DE) and RNA 6000 Nano lab-on chip electrophoresis 
(Agilent Technologies, Inc., Palo Alto, CA).  
Enrichment of bacterial RNA.  The bacterial RNA was further enriched from 
total RNA by using MICROBEnrichTM kit (Ambion, Inc., Austin, TX) to remove 
mammalian ribosomal RNAs and mRNA.  The quality and quantity of enriched bacterial 
RNA were compared to those of total RNA by RNA 6000 Nano lab-on chip 
electrophoresis (Agilent Technologies, Inc., Palo Alto, CA). 
 
RFDD-PCR.  The analysis was carried out as described in detail in the protocol 
from the displayPROFILETM kit developed by Qbiogene, Morgan Irvine, CA (Fig. III-1).  
Briefly, 500 ng enriched total RNA was reverse-transcribed using 0.75µM N8 randomized 
primer and 100 units reverse transcriptase in 25 µl volume. The reaction was incubated at 
42 °C for 2 h. For second-strand synthesis, a 50µl mix consisting of buffer, dNTPs, 12 U 
DNA polymerase I, and 0·8 U RNase H was added. The reaction mixture was incubated at 
16 °C for 2 h and subsequently phenol/chloroform extracted, precipitated by ethanol and 
dissolved in 20 µl H2O.  Total 10 µl of cDNA was checked on an agarose gel for cDNA 
smear between 100 and 2000 bp. 
 75
 
Figure III-1. Schematic outline of the RFDD-PCR technology. Adopted from 
















N8 randomized primer 
 30        31       32 
32 
The remaining 10µl cDNA was digested with TaqI endonuclease at 65 °C for 2 h. 
The RFDD-PCR template was completed by ligating the digest to adaptor mix (a standard 
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adaptor and an EP adaptor containing an extension protection group) at 37 °C for 3 h 
using T4 DNA ligase.  The incubation was carried out at 37 °C and not the standard 
16 °C to maintain the TaqI endonuclease activity during the ligation.  This prevented 
religation of cDNA TaqI fragments, but not adaptor ligation, since the latter did not re-
establish the TaqI site. 
The template was PCR amplified using a 0-extension primer complementary to 
the EP adaptor in combination with a 3-extension primer recognizing the standard adaptor 
and the three nucleotides adjacent to the TaqI site.  The 0-extension primer was kinase-
labelled with [ -33P]dATP (MP biomedicals, Irvine, CA) .  All PCR reactions were 
carried out in a 20 µl volume using 0·2 µl template and standard concentration of dNTPs 
and primers, using the following “touch down” PCR-amplification profile: initial 
denaturation 94 °C, 1 min, then for the first 10 cycles: 94 °C, 30 s; 60 °C with touchdown 
by 0·5 °C for each cycle until 55 °C is reached; 72 °C, 1 min, and for the last 25 cycles: 
94 °C, 30 s; 55 °C, 30 s; 72 °C, 1 min. 
The complete analysis was performed using radioactive labelling.  For each 
template, 32 PCR reactions using the [ -33P]dATP-labelled 0-extension primer in 
combination with the 32 different 3-extension primers (NNA/G or NNC/T) were 
performed.  The PCR products were resolved on a standard 6% polyacrylamide 
sequencing gel and dried onto Whatman paper. Bands that are indicated to be 
differentially expressed were quantified on a phosphorimager (Bio-Rad, Hercules, CA).  
The dried gel was lined up with markings on the film and the fragments were excised 
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from the gel.  The gene fragments were eluted in 50 µl Tris-EDTA buffer and reamplified 
using the same PCR conditions and primers as in the initial PCR reaction. 
 
Sequence analysis of differentially amplified bands.  Each reamplified 
fragments were cloned into the blue/white cloning vector pGEM-T-easy (Promega, 
Madison, WI) according to the manufacturer’s instructions.  Two clones from each 
cloning were submitted for sequencing (Macrogen, Korea).  Using the sequence assembly 
program Sequencher (Gene Code Corporation, Ann Arbor, MI), the nucleotide sequences 
obtained were aligned to assemble larger contiguous sequences (contigs).  These 
sequences were compared to protein and nucleic acid sequence databases using the 
BLAST alignment programs. 
 
RESULTS AND DISCUSSION 
 
Extraction of RNA from intracellular C. jejuni. Any RNA extraction method 
must be rapid enough to prevent degradation of shot half-life mRNA (~2 min), and must 
prevent artifactual in transcription during the bacterial recovery and extraction processes. 
DD technology requires pure bacterial RNA.  Otherwise the preponderance of host RNA 
would effectively compete for the available random primers, then reducing the specific 
activity of the bacterial component. So it is critical to purify the bacterial RNA from the 
much more abundant host RNA.  We have extended pure bacterial RNA extraction 
method to rapidly isolate Campylobacter total RNA from epithelial cell infection models 
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free from most of host RNA (Fig. III-2) through differential lysis with simultaneous 
protection from degradation of the bacterial mRNA and removing polyadenylated 
mRNAs along with eukaryotic rRNAs by magnetic beads, derivatized with an 
oligonucleotide that hybridizes to the capture oligonucleotide and to the polyadenylated 
3’ ends of eukaryotic mRNAs.  The resulting RNA will contain total bacterial RNA, and 
other small RNAs (5S, tRNAs) from the eukaryotic RNA population. 
 
Use of RFDD-PCR for analysis of C. jejuni colonization/invasion-related gene 
expression.  The RFDD-PCR technology relates gene expression to the concentration of 
the corresponding cDNA amplified by PCR, as in traditional DD-PCR.  Double-stranded 
cDNA was synthesized from total RNA and digested with the TaqI restriction enzyme.  
Following digestion and adaptor ligation, the template was amplified using a 0-extension 
primer combined with a 3-extension primer.  The 3-extension primer binds to the 
specially designed adaptor, which has three extra bases (NNN) that extend past the 
adaptor junction.  These three bases determined which subpopulation of cDNA fragment 
would be amplified in the reaction.  Thus, each PCR reaction only amplified a specific 
subset of cDNA fragments that had a specific three-base sequence upstream of the TaqI 
restriction site.  To amplify all subsets, which provide a complete cross section of all the 
expressed sequences, only 64 for eukaryotes, and 32 for prokaryotes different primers are 
necessary.  Visualization of the PCR products was obtained by labeling of the 0-
extension primer.  Fragments with two 3-extension primers will be amplified if the three-
 79
 
base extension matches the sequence adjacent to the TaqI restriction sites at both ends, 
but will not be labeled by the 0-extension primer.  
The purpose of the analysis was to identify constitutive changes in gene 
expression during infection with epithelial cells.  Therefore, RNA for RFDD-PCR 
analysis was isolated without co-culture with epithelial cells of wide-type strains as 
control.  The RFDD-PCR products were analyzed with the radioactively labeled 0-
extension primer (Fig. III-3).  The 32 radioisotopic profiles of the ‘induced’ J81-176 
strain and ‘control’ J81-176 strain were compared on the radiogram.  The PCR products 
having at least fivefold difference in expression were considered in the analysis.  In 
total, twenty fragments met the above criteria.  These fragments were excised from the 
gel; DNA was eluted, and re-amplified to get the same size PCR products.  The cloned 
fragments were sequenced and databases were searched for homology.  It turns out that 
they all originated from the Campylobacter ribosomal RNA genes.  
 
Reasons of failure to isolate differentially expressed gene fragments.  Several 
reasons can lead to fail to isolate differentially expressed gene fragments.  Taken together, 
there are two major ones.  First of all, the yields of Campylobacter RNA are much lower 
than host epithelial cell RNA in extracted total RNA.  The number of internalized 
Campylobacter increase with greater bacterial concentrations but even with the most 
invasive strains only one to three bacteria were internalized per cell (29, 30), not to 
mention the other average strains, which means bacterial RNA yields in total RNA 
mixture are hundred times lower than eukaryotic RNA (200).  Therefore, purifying total 
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RNA from a mixture of eukaryotic cells and bacteria could result in a vast excess of 
eukaryotic cellular RNA and very little bacterial RNA.  Too little Campylobacter RNA is 
present for generating adequate signals in RFDD-PCR.  Secondly, even after enrichment 
of bacterial RNA, expression profile of bacterial mRNA is also embedded in the noise of 
bacterial ribosomal RNA.  In principle, the 16 S and 23 S rRNAs can be extracted from 
the total RNA by hybridization to beads coated with conserved 16 S or 23 S rDNA 
sequences.  But in practice because the stable RNAs are 20-50 times more abundant than 
all combined mRNAs, a 1% difference in the efficiency of removal of stable RNA 
between the ‘control’ and ‘induced’ RNA constitutes a difference larger than that of the 
expression of many mRNAs.  Therefore, bacterial differential display must be practiced 
on the total RNA population, which leads to generation of many false positive in weak 
signal vs. strong noise environment. 
 
RFDD-PCR as a prokaryotic gene expression technology.  There are currently 
a number of different technologies available for studying gene expression in both 
eukaryotic and prokaryotic organisms (84, 234) and several aspects require consideration 
in the choice of method.  For instance, it should be clarified how reproducible the method 
is, what comprehensive coverage the method provides, whether the method is dependent 
on the organism being studied and, finally, whether the method can detect low-abundance 
transcripts. Differential display should, in principle, be a very useful tool to identify 
genes in bacteria that lack a genetic system or for which a ‘reverse genetics’ approach has 
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failed.  However, there are only limited number of reports and has not been adopted 
widely by microbiologists, not to mention for studying bacteria host interactions.  
Several factors have contributed to the poor development of bacterial differential 
display.  Firstly, because prokaryotic mRNAs lack stable poly(A) tails there is no 
straightforward way to reverse-transcribe mRNA at the exclusion of stable RNA species 
which can potentially overwhelm the experiment (166).  A second factor, which makes 
contribution, is that this technique generates false positive frequently, which is partly due 
to the density of sampling of the mRNA population.  An aliquot of reverse transcription 
reaction is used as a DNA template for PCR amplification in a second tube after the 
synthesis of the first cDNA strand from the total RNA pool by this reaction in a first tube, 
which in largely lower the density of sampling.  In turn, it enhances the chance of getting 
sequences of contaminating background DNA, which are false positives.  An increase in 
the density of sampling of the mRNA population should allow the multiple sampling of 
differentially expressed messages. 
Recently, cDNA array hybridization techniques have become increasingly used 
for the study of eukaryotic and prokaryotic gene expression (234).  Gene fragments are 
spotted down on a surface and different probes prepared from RNA samples are 
hybridized onto the cDNA arrays to visualize differences in expression levels.  The main 
restriction to the application of micro-arrays is the requirement of access to extensive 
genome sequence information in order to synthesize the gene fragment arrays for the 
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specific organism, which in Campylobacter, would not be a problem due to the 
availability of complete genome sequence (178). 
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Figure III-2. Bacterial and cellular total RNA were isolated using RNeasy Mini kit.  The 
bacterial RNA was further enriched from total RNA by MICROBEnrich kit.  Ribosomal 
RNAs before and after the enrichment by removing eukaryotic RNA showed by RNA 
6000 Nano assay (eukaryotic ribosomal RNA including 18S and 28S rRNA; prokaryotic 
ribosomal RNA including 16S and 23S rRNA). 
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Figure III-3. Example of amplified RFDD-PCR fragments, image taken by PharosFX 
plus imager system (Bio-Rad, CA). The DNA products of RFDD-PCR reactions using 
the RNA of T84-associated C. jejuni 81-176 (+) and C. jejuni 81-176 in culture (-) were 
analyzed in adjacent wells by 6% acrylamide gel, and signals were visualized with 
ImageQuant software. Each pair of RFDD-PCR reaction was driven by one of the thirty-
two selection primers. Rectangle indicated DNA bands with 5-fold different 
radioactivities in both T84 cell associated bacteria and bacteria in culture which were 
subsequently cut out, reamplified, cloned into sequencing vector and sequenced. The 
products of ten representative pairs of RFDD-PCR reactions (out of 32) are partially 
presented. 
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CHAPTER IV.  CAMPYLOBACTER JEJUNI/COLI INDUCES 
POLARIZED SECRETION OF INTERLEUKIN-8 IN HUMAN 
INTESTINAL EPITHELIAL CELLS 
 
ABSTRACT 
    Campylobacter is one of the leading causes of acute inflammatory bacterial 
diarrhea.  Campylobacter colonizes and infects the intestinal epithelium.  The intestinal 
epithelium provides a physical barrier to bacterial infection and also functions as a sensor 
of bacterial infection by secreting proinflammatory cytokines.  This study examined 
Campylobacter-induced proinflammatory cytokine interleukin (IL)-8 secretion in 
polarized human colonic epithelial cells T84.  Campylobacter induced IL-8 but not TNF-
α secretion in polarized T84 cells.  More significantly, no matter whether the bacteria 
were inoculated from the apical or basolateral surface, the polarized epithelial cells 
secreted IL-8 predominantly to the basolateral side where the epithelial cells were in 
contact with leukocytes in vivo.  There was no statistically significant correlation between 
the IL-8 secreting levels and the invasion or transcytosis abilities of Campylobacter.  
Treating the epithelial cells with conditioned supernatants (bacteria supernatant-T84 co-
culture supernatants) induced the IL-8 secretion to the level similar to that induced by the 
bacterial inoculation, suggesting that live, intact bacteria are not required for the 
induction of IL-8 secretion.  Treating the conditioned supernatants with protease K, heat, 
 86
 
DNase I, or polymyxin B led to different levels of reduction of IL-8 secretion, suggesting 
that the multiple bacterial factors are involved in the induction of IL-8 secretion.  
Furthermore, C. jejuni induced IκBα degradation, and NF-κB inhibitor TPCK blocked 
Campylobacter-induced IL-8 secretion.  These results demonstrated that C. jejuni 
induced basolateral-polarized secretion of IL-8 in human intestinal epithelial cells, and 
that C. jejuni-induced IL-8 secretion was NF-κB-dependent. 
 
INTRODUCTION 
The Campylobacter jejuni and Campylobacter coli are among the most frequent 
causes of foodborne bacterial gastroenteritis in humans worldwide (213).  Infections 
caused by Campylobacter mostly manifest acute, self-limiting enteritis with diarrhea, 
fever, vomiting, and abdominal cramps (48, 175).  A localized acute inflammatory 
response, which can lead to tissue damage, has been observed from both animal studies 
(176, 177) and clinical cases (32).  The pathogenic mechanisms responsible for human 
acute intestinal infection of Campylobacter are not fully understood.   
Epithelium is the initial defensive line against pathogenic threats.  It provides a 
physical barrier for bacterial infection.  In addition, it can function as a sensor of bacterial 
infection for the immune system.  The interaction of bacteria with the intestinal 
epithelium could induce the secretion of a panel of proinflammatory cytokines, which 
provide the earliest warning signs for the immune system (145, 202).  One of the major 
proinflammatory cytokines secreted by the intestinal epithelial cells is interleukin-8 (IL-
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8) (59, 60, 110), a chemoattractant that recruits neutrophils to the infected site.  The 
infection of a human embryo intestinal epithelial cell line INT407 in vitro by C. jejuni 
induced secretion of IL-8 (90).  The bacterial factors that induce IL-8 secretion of 
epithelial cells remain to be identified.  Live, intact Campylobacter (90) or 
Campylobacter-secreted cytolethal distending toxin (CDT) (91) has been shown to be 
able to induce IL-8 secretion.  A recent report showed that C. jejuni-induced IL-8 
secretion required C. jejuni gene products that were expressed upon contacting with 
epithelial cells and the activation of MAP kinase ERK in epithelial cells (223).  Flagellin 
of enteric bacteria, such as Salmonella, has been shown as a major inducer of IL-8 (77).  
However, the flagellin of C. jejuni appeared to be a poor stimulator of IL-8 (223).  Recent 
studies have shown that common microbial components, such as lipopolysaccharide 
(LPS) (186), bacterial DNAs that contain unmethylated CpG motif (5),  and 
peptidoglycan (PGN) (204), can evoke epithelial IL-8 production by activating Toll-like 
receptors (TLRs), a family of pattern-recognition receptor that bind to conserved 
microbial structures and activate the innate immunity (6, 151).   
Most studies thus far have been done using unpolarized epithelial cells.  However, 
the intestinal epithelial cells in vivo are polarized with the apical surface faces the 
intestinal lumen.  Two surfaces of polarized epithelial cells express different proteins and 
different TLRs (19, 164).  It has been shown in vitro that Campylobacter colonized, 
invaded and transmigrated across polarized intestinal epithelial cells (127, 159).  It is 
unknown whether the interaction of Campylobacter with polarized human intestinal 
epithelial cells will induce IL-8 production, and if so, whether the colonization, invasion, 
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and transmigration of Campylobacter are associated with the induction of IL-8 secretion 
in polarized epithelial cells.      
Nuclear factor (NF) κB is the major transcriptional regulator of proinflammatory 
cytokines in the intestinal epithelial cells (62, 165) and the main downstream target of 
TLR signaling pathway (6).  The interaction of mucosal pathogens including Salmonella 
(93), Neisseria (168), Shigella. Flexneri (58), Escherichia coli (201) with epithelial cells 
activate NF-κB.  C. jejuni has been shown to activate NF-κB in HeLa cells and human 
colonic epithelial cells (HCA-7) (154).  C. jejuni-induced secretion of proinflammatory 
chemkines GROα, γIP-10, and MCP-1 has been shown to be NF-κB dependent (96).  
Gastroenteritis caused by C. jejuni was more severe in NF-κB deficient mice than in wild 
type mice (73), further supporting the importance of NF-κB in the host responses to C. 
jejuni infection.  However, the relationship between Campylobacter-induced NF-κB 
activation and IL-8 secretion remains to be established. 
In this study, we examined Campylobacter-induced IL-8 secretion in polarized 
human intestinal epithelial cells, and demonstrated that C. jejuni induced a polarized IL-8 
secretion in polarized human colonic epithelial cells (T84), and that this polarized IL-8 
secretion required the activation of NF-κB and involved multiple bacterial factors whose 





MATERIALS AND METHODS 
Bacterial strains and growth conditions.  Five Campylobacter jejuni and three 
C. coli chicken meat isolates were routinely grown on Mueller-Hinton (MH) agar (Difco 
Lab, Detroit, MI) containing 5% (v/v) lysed horse blood at 37 °C under a microaerophilic 
atmosphere (85% N2, 10% CO2, and 5% O2).  Human clinical strains C. jejuni 81-176 (82, 
171) and NCTC11168 (210) were kindly provided by Dr. P. Guerry-Kopecko at Naval 
Medical Research Center (Bethesda, MD) and Dr. Alain Stintzi at Ottawa institute of 
systems biology, respectively.  The eight C. jejuni and C. coli isolates used in this studies 
were selected based on their distinct DNA fingerprinting profiles of pulsed-field gel 
electrophoresis (PFGE) from 378 Campylobacter isolates that were recovered from retail 
raw meats in the Washington, D.C. area from June 1999 to July 2000 (235). 
 
Cell culture.  T84 cells (human colonic epithelial cell line, ATCC CCL-248) 
were maintained in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s 
F12 medium containing 1.2 g/L sodium bicarbonate, 2.5 mM L-glutamine, 15 mM 
HEPES and 0.5 mM sodium pyruvate (Invitrogen, San Diego, CA) supplemented with 
5% (v/v) fetal bovine serum, penicillin and streptomycin (5% DME/F12), as 
recommended by the American Type Culture Collection, Manassas, VA.  To establish 
polarized monolayers, T84 cells seeded onto transwells (0.33 cm2) with 3.0-µm pore-size 
clear polyester membranes (Corning Costar Corp., Cambridge, MA).  The medium was 
changed every other day.  The polarization of the epithelial monolayers was monitored by 
transepithelial resistance measured by Millicell-ERS (Millipore, Billerica, MA).  The 
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transepithelial resistance of T84 epithelial monolayers normally reaches 1,400 Ω /cm2 or 
above after two weeks culture. 
 
Inhibitors.  N-α-p-tosyl-L-phenylalanine chloromethyl ketone (TPCK), a NF-κB 
inhibitor  (Sigma-Aldrich, St. Louis, MO) (36) was stored in dimethyl sulfoxide (DMSO) 
at -20°C. Cells were preincubated for 30 min with TPCK (50 µM), and the inhibitor was 
included in the inoculation medium. Cycloheximide (148), an inhibitor of eukaryotic but 
not prokaryotic protein synthesis, and polymyxin B (103, 204), which binds and 
neutralizes LPS, were purchased from Sigma-Aldrich. 
 
Analyses for IL-8 secretion.  Polarized T84 monolayers cultured on transwells 
(resistance > 1,400 Ω /cm2) were washed three times with PBS and two times with the 
invasion medium (5% DME/F12 without antibiotics) at 37oC.  Bacteria were cultured for 
18 h and harvested from the plates with PBS.  T84 monolayers were treated by one of the 
following conditions: (a) inoculation of Campylobacter, 4×106 CFU (multiplicity of 
infection (MOI) ~ 10) in the invasion medium either from the apical or basolateral 
chamber of transwells, (b) addition of conditioned supernatants generated from the apical 
and basolateral culture media to the apical and basolateral culture chambers, and (c) 
addition of polymyxin B-treated DNA extract of C. jejuni 81-176, and (d) addition of 
TNF-α (1-100 ng/ml) to the basolateral chamber.  The epithelial cells were incubated for 
times indicated in a 5% CO2 incubator at 37°C.  The culture media from the apical and 
basolateral chamber were individually collected and centrifuged for 20 min at 13,000xg 
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to remove bacteria.  A cocktail of protease inhibitors (Sigma-Aldrich) was added to the 
supernatant to prevent proteins from degradation.  The amount of IL-8 and TNF-α in the 
supernatants was determined by enzyme-linked immunosorbent assay (ELISA).  Mouse 
anti-human IL-8 monoclonal antibody (mAb) and mouse anti-human TNF-α mAb (BD 
Pharmingen) as capturing antibodies, biotinylated mouse anti-human IL-8 and anti-
human TNF-α mAb (BD Pharmingen, San Diego, CA) as detecting antibodies, and 
streptavidin-alkaline phosphatase (Southern Biotech. Assoc. Inc., Birmingham, AL) and 
substrate p-nitrophenylphosphate disodium (pNPP, Sigma-Aldrich) to visualize bound 
antibodies.  Recombinant human IL-8 and TNF-α (BD Pharmingen) with known 
concentrations were used to established standard curves.  
 
Preparation of conditioned supernatants from the Campylobacter-epithelial 
cell co-culture.  Conditioned media were prepared using a previously described 
procedure with minor modifications (77). Typically, polarized T84 epithelial monolayers 
were washed three times with PBS and two times with invasion medium, and were 
allowed to equilibrate in the invasion medium for 30 min at 37ºC.  C. jejuni 81-176 
suspension (around 4×106 CFU) in 0.1 ml invasion medium was inoculated apically and 
incubated at 37ºC for 4 h. After the 4 h-incubation, the apical and basolateral media were 
collected individually and centrifuged for 20 min at 13,000xg, and the supernatants were 
stored at –20ºC for future use. The same amount of bacteria was suspended in 0.1 ml 
invasion medium and incubated alone for 4 h at 37ºC.  The cultures were centrifuged to 
remove bacteria, and the supernatant was collected and stored at -20ºC.  To inactivate 
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heat-sensitive proteins, the collected basolateral conditioned supernatant was boiled for 
20 min.  To remove most of protein factors, the conditioned supernatant was treated with 
protease K (100 µg/ml, Invitrogen) at 56ºC overnight, followed by a 20 min-incubation at 
100ºC to inactivate protease K.  To remove bacterial DNA, the conditional supernatant 
was treated with DNase I (10U/ml) (New England Biolab, Ipswich, MA) 37ºC for 2 h 
respectively.  The treated supernatants were analyzed using SDS-PAGE (12%) and 
agarose gel to confirm the removal of proteins by protease K and bacterial DNA by 
DNase I (data not shown).  The supernatant and C. jejuni 81-176 DNA extract were 
incubated with polymyxin B (100 µg/ml) to neutralize LPS. 
   
Adherence, internalization, and transcytosis assays.  The adherence, invasion, 
and transcytosis of  Campylobacter  in polarized epithelial cells were analyzed as 
previously described (159).  Typically, polarized T84 epithelial monolayers were washed 
three times with PBS and two times with invasion medium.  Campylobacter suspension 
(around 4×106 CFU, MOI ~ 10) in 0.1 ml invasion medium was inoculated apically and 
incubated at 37ºC for 4 h.  The transepithelial resistance was checked before and after the 
incubation with the bacteria.  After the 4 h-incubation, bacteria, which transmigrate 
across the cell monolayer into the basolateral medium, were enumerated by plating 10-
fold serial dilutions of the basolateral medium on MH-blood agar plates.  Cell-associated 
bacteria were released by lysing T84 cells with 1% saponin after washes.  After 
incubation for 5 min and vortex vigorously for 2 min, serial dilutions of the lysates were 
plated on MH-blood plates.  To determine internalized bacteria, T84 epithelial 
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monolayers were washed and incubated with gentamicin (100 µg/ml) in invasion medium 
at both the apical and basolateral chambers for 2 h to kill extracellular bacteria.  Then 
cells were washed and lysed.  Each assay was performed in triplicate wells and repeated 
at least three times.  The number of adhered, internalized or translocated bacteria was 
plotted as a percentage of the starting viable inoculum. 
  
  Analysis for NF-κB activation.  The activation of NF-κB was analyzed by 
following the degradation of NF-κB inhibitor IκB-α.  Epithelial cells T84 were incubated 
with C. jejuni 81-176 (MOI ~10) in the presence of protein synthesis inhibitor, 
cyclohexamide (10 ng/ml, Sigma-Aldrich), which block protein synthesis, for varying 
lengths of times.  By the end of the incubation, the epithelial cells were washed with cold 
PBS and lysed with a lysis buffer (20 mM Tris-HCl, pH7.5, 150 mM NaCl, 1 mM EGTA, 
1% NP-40, 1 mM MgCl2, 50 mM NaF, 1 mM Na3VO4, 10 mM Na4P2O7, and 1% 
protease inhibitor cocktail) at 4oC.  After centrifugation at 13,000xg for 30 min at 4ºC to 
remove cell debris and bacteria, the protein concentration of supernatant was determined 
by using BCA protein assay (Pierce, Rockford, IL).  Equal amounts (20 µg) of cell 
lysates were subjected to SDS-PAGE and Western blot, probed with rabbit anti-IκB-α 
antibody (Santa-Cruz Biotechnology, Santa Cruz, CA).  The blots were stripped and 







Polarized T84 cells basolaterally secrete IL-8 but not TNF-α after apical 
exposure to C. jejuni 81-176.  Campylobacter-induced IL-8 and TNF-α secretion in 
polarized human colonic epithelial cells T84 was determined.  C. jejuni 81-176 was 
inoculated apically at a MOI of 10:1.  Secretion of IL-8 was detected at the basolateral 
media 6 h post inoculation, the earliest point tested (Fig. IV-1).  By 24 h, the 
concentration of IL-8 in the basolateral media reached to100 pg/ml.  In contrast, there 
was no significant amount of IL-8 detected in the apical media (Fig. IV-1).  This 
indicates that Campylobacter–induced IL-8 secretion is basolaterally polarized.  In 
addition, no significant increase in TNF-α secretion was detected in both the apical and 
basolateral media 24 h post the inoculation (Fig. IV-1).   
 
Increased IL-8 secretion following Campylobacter infection is not mediated 
by secreted TNF-α.  To test whether the IL-8 secretion by polarized T84 cells was 
induced by the small amount of TNF-α induced by Campylobacter, we determined the 
IL-8 secreting level of polarized T84 cells that were treated with different concentrations 
of TNF-α for 24 h.  Figure IV-2 showed that the basolateral secretion of IL-8 by T84 
cells increased in TNF-α dose-dependent manner.  Induction of IL-8 to 100 ng/ml in the 
basolateral medium required more than 50 ng/ml TNF-α, which was much higher than 
the levels of TNF-α induced by Campylobacter (10 pg/ml, Fig. IV-1), suggesting that 





Campylobacter-induced IL-8 secretion is independent of Campylobacter 
invasion and transcytosis abilities.  To test the interrelationship between the IL-8 
secretion induction and invasion/transcytosis abilities of Campylobacter, we determined 
the adherence, invasion, transcytosis, and IL-8 induction abilities of eight Campylobacter 
retail chicken meat isolates and two human clinic isolates that were previously shown 
different invasion abilities in non-polarized T84 cells(97, 108).  The ten Campylobacter 
strains displayed similar adherence abilities, but different invasion and transcytosis 
abilities (Fig. IV-3).  Human clinical strain C. jejuni 81-176 displayed the highest 
invasion and transcytosis efficiencies among ten isolates tested.  The invasion ability of C. 
jejuni 65 was 40 fold less than that of C. jejuni 81-176, and no transcytosis was detected 
with C. jejuni 587 and 602 (Fig. IV-3).  When inoculated from the apical surface of 
polarized T84 cells, all the ten strains of Campylobacter were able to induce IL-8 
secretion primarily to the basolateral media despite of their differences in the invasion 
and transcytosis efficiencies (Fig. IV-4A).  Human clinic strain C. jejuni 81-176 that has 
the highest invasion and transcytosis efficiencies among the ten strains tested (Fig. IV-3) 
induced a higher level of IL-8 secretion than eight other strains (Fig. IV-4A).  However, 
no significant correlation was found between Campylobacter-induced IL-8 secretion with 
either Campylobacter invasion or transcytosis efficiency when analyzed by linear 
regression.  This suggests that the invasion and transmigration of Campylobacter is not 




Campylobacter-induced polarized IL-8 secretion from T84 cells is 
independent of Campylobacter entry direction.  To test whether the inoculation 
direction affects the polarity of Campylobacter-induced IL-8 secretion, we compared the 
IL-8 secreting levels induced by apical inoculation of C. jejuni 81-176 with those induced 
by basolateral inoculation of C. jejuni 81-176.  Both apical and basolateral inoculation of 
the polarized T84 epithelial cells with eight Campylobacter retail meat isolates and two 
human clinic isolates resulted in a substantial increase in IL-8 secretion compared to 
uninfected T84 cells (Fig. IV-4B).  The levels of IL-8 induced by the basolateral 
inoculation of Campylobacter were either similar to or slightly higher than those induced 
by the apical inoculation.  Similar to the apical inoculation, the basolateral inoculation 
induced IL-8 secretion primarily to the basolateral media, indicating that IL-8 was 
preferentially secreted at the basolateral surface no matter whether Campylobacter were 
inoculated from the apical or basolateral surface.    
 
Multiple bacterial factors are involved in IL-8 induction.  To test whether the 
induction of IL-8 secretion requires live Campylobacter, polarized T84 cells were treated 
apically or basolaterally with the bacteria-free apical and basolateral conditional 
supernatants.  The bacteria-free conditional supernatants were generated from the apical 
or basolateral media of polarized T84 cells that were inoculated with C. jejuni 81-176 
apically for 4 h.  In addition, polarized T84 cells treated with bacteria culture supernatant 
apically was used as a control.  As shown in Figure IV-5, regardless of the type of the 
conditional supernatant that T84 cells were incubated with, a significant amount of IL-8 
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was induced in a basolaterally polarized manner.  This suggests that live, intact bacteria 
are not required for IL-8 secretion.  The levels of IL-8 induced by the apical and 
basolateral conditioned supernatants were similar, but higher than that induced by 
bacterial culture supernatant (Fig. IV-5), suggesting that bacterial factors secreted upon 
Campylobacter-T84 cells interaction are involved in the induction of IL-8 secretion.  To 
test which bacterial factors in the conditioned media contribute to the induction of IL-8 
secretion, we treated the basolateral conditioned supernatant with DNase to remove 
bacterial DNA, ligands for TLR 9, polymyxin B to remove LPS, ligands for TLR4, 
protease K to remove proteins, and heat to denature proteins.  SDS-PAGE and agarose 
gel analyses showed that most of DNA and proteins were degraded by DNase and 
protease K treatment (data not shown).  The effects of different treatments on the ability 
of the basolateral-conditioned supernatants to trigger IL-8 secretion were determined.  
Both boiling alone and protease K treatment plus boiling significantly decreased IL-8 
secreting level, while protease K plus boiling was most effective in reducing IL-8 
secretion among all the treatments with a 70% reduction of the basolateral secretion of 
IL-8 (Fig. IV-6).  This suggests that bacterial secreted proteins play roles in IL-8 
induction.  While DNase or polymyxin B alone did not significantly change the ability of 
the basolateral-conditioned supernatant to induce IL-8 secreting, incubating polarized 
T84 cells with polymyxin B-treated DNA extract from C. jejuni 81-176 significantly 
increased IL-8 secretion (Fig. IV-6).  Here, the polymyxin B treatment was used to 
remove LPS contraindication in Campylobacter DNA extract.  This result suggests that 
both Campylobacter DNA and LPS are involved in the induction of IL-8.  Taken together, 
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multiple secreted factors of Campylobacter appear to be involved in the induction of IL-8 
secretion.  
 
Campylobacter induces IL-8 secretion is NF-κB-dependent.  NF-κB is an 
important regulator of IL-8 expression (62, 165).  To determine whether Campylobacter-
induced IL-8 secretion is dependent NF-κB activation, we first test whether 
Campylobacter can induce the activation of NF-κB.  The activation of NF-κB requires 
the degradation of IκB-α, an inhibitory subunit of the complex by the proteasome (153).  
The degradation of IκB-α was followed by Western blot (Fig. IV-7A) using TNF-α 
treated T84 cells as a positive control.  TNF-α treatment (10ng/ml) significantly 
decreased IκBα level at 30 min (Fig. IV-7A).  Inoculation of C. jejuni 81-176 induced 
the degradation of IκB-α in a time-dependent manner.  After incubated with the bacteria 
for 120 min, the amount of IκB-α in the cell lysate decreased to the level similar to that 
of TNF-α-treated T84 cells.  This indicates that Campylobacter inoculation induces NF-
κB activation in T84 cells.  Next, we tested the effect of a proteasome inhibitor TPCK, 
which was shown to be able to effectively inhibit IκB degradation (43, 230), on 
Campylobacter-induced IL-8 secretion.  T84 cells were pretreated with TPCK (50 µM) 
for 30 min before the inoculation and during the inoculation in both the apical and 
basolateral media.  The TPCK treatment reduced the IL-8 secretion to a level similar to 
that of control T84 cells that were not inoculated with the bacteria (Fig. IV-7B).  This 
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result indicates that the NF-κB activation is required for Campylobacter-induced 




The interaction of enteric pathogens, including Campylobacter, with human 
intestinal epithelial cells induced proinflammatory cytokine secretion (90, 91, 145, 202) , 
which initiates the local inflammation.  One of the early cytokines that were induced by 
enteric bacteria is IL-8 (59, 60, 110) that chemoattracts neutrophils and T cells to 
infection sites (115, 129).  Studies presented here show that C. jejuni induced NF-κB 
activation and a basolaterally dominant IL-8 secretion in polarized human colonic 
epithelial cells (T84), and this polarized IL-8 secretion requires the activation of NF-κB 
and involves multiple bacterial factors.   
Similar to other enteric pathogens, the interaction of C. jejuni and C. coli, with 
polarized human intestinal epithelial cells T84 induces basolaterally polarized secretion 
of IL-8, which provides a signal for the transmigration of subepithial neutrophils to the 
apical surface (25, 144, 145, 203).  Furthermore, we found that the polarity of IL-8 
secretion was independent of Campylobacter-inoculation sites, suggesting that the 
basolateral secretion of IL-8 does not require the transmigration of C. jejuni from the 
apical to basolateral sides.  Our observation that Campylobacter isolates that failed to 
transcytose across polarized T84 cells were able to trigger the basolateral secretion of IL-
8 further supports this notion.  This ensures the induction of inflammatory responses 
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despite the varying abilities of infecting Campylobacter strains to transmigrate.  The 
basolateral secretion of IL-8 independently of inoculation directions suggests that such 
polarized IL-8 secretion is the intrinsic property of the epithelial cells.  The underlying 
mechanism for the polarized secretion of IL-8 by epithelial cells is unknown. 
Compare to previously published studies (90, 91), the levels of IL-8 induced by 
Campylobacter showed in this study appears to be relatively low.  There are several 
possible explanations.  First, human colonic epithelial cells T84 cells that can form 
polarized monolayer when grown on filter were used to mimic intestinal epithelium 
instead of non-polarized human embryo intestinal epithelial cell INT407.  Secondly, a 
ratio of bacteria to epithelial cells at 10 to 1 was used in this study instead of 100 to 1 
used by most of previous studies (90, 91).  The IL-8 secretion level has been shown to be 
dependent of inoculation doses of Campylobacter.  Considering the dose effect, the IL-8 
secreting levels showed here are comparable to those previously reported for 
Campylobacter (90).   
A previous study demonstrated a correlation between the levels of IL-8 secretion 
induction and adherence and/or invasion by Campylobacter using a group of human 
clinical strains, a set of mutants of C. jejuni 81-176 (90), and human embryo intestinal 
epithelial cells INT407 as the model.   In this study, we compared the IL-8 secreting 
levels induced by a group of chicken meat isolates with similar adherent abilities but 
different invasion and transcytosis abilities using polarized human intestinal epithelial 
cells T84.  We didn’t find any significant correlation between IL-8 secretion levels and 
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invasion or transcytosis efficacies (90).  Because the strains used here have similar 
adherent abilities, our observation does not exclude the possible correlation between the 
levels of IL-8 secretion induction and adherence of Campylobacter to T84 cells.    
The studies presented here showed that bacteria-free conditioned supernatants 
generated from basolateral and apical media of T84 cells that were inoculated with C. 
jejuni 81-176 for 4 h induced IL-8 secretion to the level similar to that induced by direct 
bacterial inoculation, which indicates that live, intact bacteria are not required for 
induction of IL-8 secretion and that the induction of IL-8 secretion in T84 cells involved 
molecules secreted by C. jejuni 81-176.  The conditioned supernatants were more 
effective than the bacterial culture supernatant in the induction of IL-8 secretion, 
suggesting that the interaction between the bacteria and T84 cells induces the secretion of 
bacterial factors that are important for IL-8 induction.  This is consistent with previous 
studies of other enteric pathogens (25, 60).  Interestingly, the basolateral and apical 
conditioned supernatants induced IL-8 secretion to similar levels, despite that there was a 
much fewer number of bacteria in the basolateral media than that in the apical media 
since only less than 1% of Campylobacter inoculated transmigrated from the apical into 
the basolateral chamber.  This may due to a rapid transcytosis of Campylobacter-secreted 
factors independent of the bacterial transcytosis.  The transcytosis of purified LPS and the 
association of LPS transcytosis with IL-8 secretion induction have been demonstrated 
previously (25), which support this hypothesis.   
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In this study, we further tested which secreted bacterial factors are important for 
IL-8 induction.  It was found that protein factors appear to be the main elements involved 
in IL-8 induction since the treatment of protease K plus boiling abolished 70% of IL-8 
basolateral secretion.  One of the protein factors is likely to be cytolethal distending toxin 
(CDT), which has been shown to be able to induce IL-8 secretion in the absence of live, 
intact bacteria (91).  Another potential candidate is flagellin.  However, Campylobacter 
flagellin was found to be a weak stimulator for IL-8 secretion (223).  The treatment with 
protease K plus boiling did not completely reduce the IL-8 secretion to the control level, 
suggesting the involvement of additional factors besides proteins.  Treating polarized T84 
cells with Campylobacter DNA alone significantly increased IL-8 secretion, suggesting 
that Campylobacter DNA, a potential ligand of TLR9, is important factor for IL-8 
induction.  Purified LPS, a TLR4 ligand, has been shown to be able to transcytose across 
polarized T84 cells and induce IL-8 secretion (25).  However, no significant effect was 
found when polarized T84 cells treated with polymyxin B, which binds and neutralizes 
LPS, or DNase, which degrades DNA, alone.  This implicates that IL-8 secretion can be 
induced by multiple bacterial factors.   
 In common with other enteric pathogens, C. jejuni-induced IL-8 secretion is NF-
κB pathway dependent, which demonstrated by the induction of IκB degradation by C. 
jejuni inoculation and the inhibition of Campylobacter-induced IL-8 secretion by a NF-
κB inhibitor.  Mellits et al. previously showed that viable C. jejuni and boiled cell-free 
extract of C. jejuni activated both NF-κB and IL-8 secretion in Hela and human colonic 
epithelial (HCA-7) cells (154).   A recent report by Hu and Hickey showed that C. jejuni 
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81-176 up-regulated the expression of mRNAs of proinflammatory chemokines MCP-1, 
MIP-1α and γIP-10 at the NF-κB dependent manner (96).  Our results provide evidence 
directly connecting Campylobacter-induced NF-κB activation and IL-8 secretion.  How 
Campylobacter triggers NF-κB activation remains to be elucidated.  Further studies are 
required to examine the role of secreted bacterial factors individual or in combination in 
NF-κB activation and IL-8 secretion induction and to understand the molecular 
mechanism by which Campylobacter triggers NF-κB activation. 
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Figure IV-1. Apical exposure of Campylobacter induces the basolateral secretion of IL-8 
but not TNF-α in polarized human intestinal epithelial T84 cells.  T84 cells were cultured 
on transwells until the transepithelial resistance (TER) reaches 1400 Ω/cm2.  C. jejuni 81-
176 was inoculated from the apical chamber at MOI ~10 and incubated at 37ºC for 0, 6, 
and 24 h.  For the 24 h time point, the cells were washed at 6 h to remove unattached 
bacteria and cultured in fresh medium for another 18 h.  The supernatants from the apical 
and basolateral chambers were collected separately, the bacteria were removed by 
centrifugation, and protease inhibitors were added to prevent protein degradation.  The 
concentrations of IL-8 and TNF-α were determined by ELISA.  Shown are the averages 
(±S.D.) of three independent experiments. 
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Figure IV-2. TNF-α -induced IL-8 secretion in polarized T84 cells.  Polarized T84 cells 
were incubated with varying concentrations of TNF- α in the basolateral chamber for 4 h 
at 37ºC.  The treatment of TNF-α did not significantly changed TER of epithelial 
monolayers.  The basolateral media were collected and the concentrations of IL-8 were 
determined using ELISA.   



















Figure IV-3. The adherence, invasion and trnascytosis abilities of different 
Campylobacter isolates in polarized human intestinal epithelial cells.  T84 cells were 
inoculated with different chicken and human clinic isolates of Campylobacter (C. coli 
and C.  jejuni) from the apical chamber of transwells at MOI ~10 and incubated at 37ºC 
for 4 h.  The medium from the basolateral chamber was collected to determine the 
number of transcytosed bacteria.  T84 cells were washed and lysed to determine the 
number of host cell-associated bacteria.  Parallel transwells were treated with 100 µg/ml 
gentamicin, washed and lysed to determine the number of internalized bacteria.  The data 
are presented as a percentage of the inoculums.  Shown are averages (±S.D.) of three 
independent experiments with triplicate samples.  Human clinical strain J81-176 was 












































Figure IV-4. Comparison of IL-8 secretion induced by different Campylobacter isolates 
inoculated apically and basolaterally.  Polarized T84 cells were inoculated from either the 
apical (A) or basolateral (B) side with one of eight chicken meat isolates and two human 
clinic isolates of Campylobacter (C. coli and C.  jejuni) at MOI ~10 and incubated for 24 
h.  At 6 h, T84 cells were washed and changed into fresh medium.  The apical and 
basolateral media were collected at 24 h, and the concentrations of IL-8 were measured 
using ELISA.  Shown are averages (±S.D.) of three independent experiments.  Human 




























































































































Figure IV-5. IL-8 secretion induced by Campylobacter culture media and conditioned 
supernatants.  Polarized T84 cells were incubated for 24 h with bacteria-free medium that 
were generated from C. jejuni 81-176 cultured in the invasion medium for 4 h or the 
apical or basolateral medium of polarized T84 cells that were inoculated with C. jejuni 
81-176 for 4 h.  The apical and basolateral media were collected, and the IL-8 levels were 






























































Figure IV-6. The effect of different treatments on the abilities of the conditioned 
supernatant to induce IL-8 secretion.  The basolateral-conditioned supernatant was 
pretreated with proteinase K (100 µg/ml) overnight, followed by a 20 min-incubation at 
100ºC, DNase I (10U/ml) or polymyxin B (100 µg/ml) at 37ºC for 2 h.  Polarized T84 
cells were incubated with the pretreated conditioned supernatants or C. jejuni 81-176 
DNA extract (25 µg/ml) in the presence of polymyxin B (50 µg/ml) in the basolateral 
chamber at 37oC for 24 h.  The apical and basolaterial media were collected, and IL-8 
concentrations were determined by ELISA. The data represent the mean (±S.D.) of three 
independent experiments and are expressed as a percentage of untreated basolateral 






































Figure IV-7. Campylobacter-induced IL-8 secretion is dependent on NF-kB activation.  
A. T84 cells were incubated with C. jejuni 81-176 (MOI ~10) in the presence of 
cycloheximide for varying lengths of time.  The cells were washed and lysed, and the cell 
lysates were analyzed using SDS-PAGE and Western blot, probing for IkBα.  The blots 
were stripped and reblotted for tubulin.  Shown are the representative results of three 
independent experiments.  B. Polarized T84 cells were incubated with C. jejuni 81-176 in 
the presence or absence of 50 mM TPCK at 37°C for 24 h.  The apical and basolateral 
media were collected, and the IL-8 concentrations were determined by ELISA.  The data 
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CHAPTER V.  GENERAL DISCUSSION AND FUTURE WORK 
Campylobacter jejuni/coli are common enteric pathogens, which cause human 
enteritis worldwide.  Although campylobacteriosis can be transmitted through different 
means, the principal vehicle of human campylobacter infection is raw or undercooked 
meat.  Raw meat can be contaminated with campylobacters, and poultry is by far the 
most important source, especially broiler chickens.  Despite frequent contamination of 
retail meat with Campylobacter, it remains unclear whether all Campylobacter in retail 
meat are pathogenic to humans and which factors specifically contribute to their 
pathogenicity.  Methodologies on specifically identifying and distinguishing pathogenic 
strains of Campylobacter from non-pathogenic ones are needed for food safety 
surveillance.    
We examined 43 C. jejuni/coli isolates with distinct DNA fingerprinting profiles 
of PFGE recovered from retail meats.  Their abilities to adhere to and invade human 
intestinal epithelial T84 cells were characterized and compared with a well-characterized 
human clinical strain, C. jejuni 81-176, in order to better assess their pathogenic potential.  
In the meanwhile, the presence of eight putative virulence genes that are potentially 
responsible for adherence and invasion, or encode cytolethal distending toxin in 
Campylobacter isolates was determined using PCR.  Our data indicated that C. jejuni and 
C. coli present in retail meat were considerably diverse in their ability to adhere to and 
invade human intestinal epithelial cells.  There was a significant correlation between the 
adherence and invasion abilities of the Campylobacter isolates.  The putative virulence 
genes were widespread among the Campylobacter isolates.  All Campylobacter isolates 
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possessed flaA, cadF, pldA, cdtA, cdtB, and cdtC, and most (91%) also contained ciaB 
gene except virB11 gene, which was found only in one isolate, C114.  VirB11 gene, 
carried by a virulence plasmid pVir, has been showed associated with greater occurrence 
of blood in patient stool.  However, C114 showed extremely low level of invasion ability, 
one possible reason could be this isolate fail to express the gene when they interact with 
host cells or it may express inactive variant of the virB11 gene.   
The prevalence of putative virulence genes among the Campylobacter isolates 
was high, but  there was no clear correlation between the presence of the genes and the 
adherence or invasion abilities of the isolates.  In order to understand the role of the genes 
in the Campylobacter pathogenesis, studies on the expression of these virulence genes in 
Campylobacter with or without interaction with host cells are needed.  In addition, 
deletion mutation studies will also provide insight on the association of these genes with 
adherence or invasion abilities of Campylobacter, and on the potential redundancy or 
overlapping functions of these genes.   
We also applied restriction fragment differential display PCR (RFDD-PCR) 
technique to identifying additional genes responsible for host adherence or invasion.  
Gene expression profiles in C. jejuni 81-176 were compared with or without contact with 
T84 cells.  In the study, we extended pure bacterial RNA extraction method to rapid 
isolation of campylobacterial total RNA from epithelial cell infection models.  However, 
we was not able to identify any differentially expressed genes of C. jejuni due to the false 
positive of all the isolated gene fragments, which were from stable bacterial ribosomal 
RNAs.  In the future, DNA microarray will be a more successful alternative approach to 
identify Campylobacter specific genes associated with colonization and invasion due to 
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the completion of C. jejuni and C. coli genome sequences.  Firstly, microarray uses either 
synthetic oligonucleotide or cDNA fragment as probes, where each sequence is unique 
and displays minimal cross-hybridization to related sequences.  Hence the probes on a 
microarray would ideally be a comprehensive representation of the expressed fraction of 
the genome.  Unlike RFDD-PCR, even using total RNA, this method can overcome the 
massive presence of ribosomal RNA and identify the real expression signals.  Secondly, 
genomic hybridization between pathogenic and non-pathogenic strains or between strains 
with or without interaction with host cells using DNA microarray can sort out the genes 
related to pathogenesis in Campylobacter.  
During Campylobacter-host cell interaction, the intestinal epithelium provides a 
physical barrier to bacterial infection and also functions as a sensor of bacterial infection 
by secreting proinflammatory cytokines.  C. jejuni/coli-induced proinflammatory 
cytokine Interleukin (IL)-8 secretion in polarized human colonic epithelial cells T84 was 
examined in our study.  C. jejun/coli induced IL-8 but not TNF-α secretion in polarized 
T84 cells.  Significantly, no matter whether the bacteria were inoculated from the apical 
or basolateral surface, the polarized epithelial cells secreted IL-8 predominantly to the 
basolateral side where the epithelial cells had contact with leukocytes in vivo.  Treating 
the epithelial cells with bacteria-free conditioned supernatants from Campylobacter-T84 
culture induced the IL-8 secretion to the level similar to that induced by the bacterial 
inoculation, suggesting that live, intact bacteria are not required for the induction of IL-8 
secretion.  Treating the conditioned supernatants with protease K, heat, DNase I, or 
polymyxin B led to different levels of reduction of IL-8 secretion, suggesting that the 
multiple bacterial factors are involved in the induction of IL-8 secretion.  Furthermore, C. 
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jejuni induced IκBα degradation, and NF-κB inhibitor TPCK blocked Campylobacter-
induced IL-8 secretion.  These results demonstrated that C. jejuni induced basolateral-
polarized secretion of IL-8 in human intestinal epithelial cells, and that C. jejuni-induced 
IL-8 secretion was NF-κB-dependent.  In addition, protease-treated supernatant inhibited 
70% of IL-8 secretion, which had the greatest effect on IL-8 production.  However, it was 
not clear what the protein factors were, and through which receptors Campylobacter 
induced host cells to secret IL-8.  In future studies, CDT and flagella antibodies can be 
used to treat the supernatants individually or together to determine if they are associated 
with IL-8 secretion.  Additionally, protease-treated supernatants can be compared with 
untreated supernatants using two dimensional gel electrophoresis to identify potential 
proteins, which can be subsequently sequenced by mass spectrum to determine their 
amino acid sequences.  The amino acid sequences can be converted to DNA sequences to 
predict the possible open reading frames.  Mmutagenesis studies of these predicted genes 
can be used to confirm the functions of the genes.  Furthermore, antibodies to host cell 
surface receptors can be used to block the receptors to elucidate cell surface receptors 
through which Campylobacter activates NF-κB pathway and induces IL-8 secretion. 
In summary, our studies demonstrated the pathogenic potential among 
Campylobacter isolates from retail meats regarding adherence and invasiveness in in 
vitro model; how the host epithelial cells reacted in response to Campylobacter infection; 
and what the players were involved in these processes.  Yet, there is still a lot of work 
that needs to be done in order to elucidate what makes some Campylobacter isolates 
more pathogenic than others; and which group(s) of genes is actually involved in C. 
jejuni colonization and invasion in genetic and molecular level.  Taking advantage of the 
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availability of the complete genome sequence of Campylobacter, research strategies such 
as DNA microarrays, reverse genetics etc. should make possilbe to delineate fundamental 
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